Patent Grant
11709155
This technology relates to the use of vapor deposition coated flow paths for improved chromatography. More specifically, this technology relates to chromatographic devices for separating analytes in a sample having coated flow paths, methods of separating analytes in a sample (for example, glycans, peptides, pesticides, and citric acid cycle metabolites) using a fluidic system that includes coated flow paths, and methods of tailoring a fluidic flow path for separation of a sample.
Analytes that interact with metal have often proven to be very challenging to separate. The desire to have high pressure capable chromatographic systems with minimal dispersion has required that flow paths decrease in diameter and be able to withstand increasingly high pressures at increasingly fast flow rates. As a result, the material of choice for chromatographic flow paths is often metallic in nature. This is despite the fact that characteristics of certain analytes, for example, biomolecules, proteins, glycans, peptides, oligonucleotides, pesticides, bisphosphonic acids, anionic metabolites, and zwitterions like amino acids and neurotransmitters, are known to have unfavorable interactions, so called chromatographic secondary interactions, with metallic surfaces.
The proposed mechanism for metal specific binding interactions requires an understanding of the Lewis theory of acid-base chemistry. Pure metals and metal alloys (along with their corresponding oxide layers) have terminal metal atoms that have characteristics of a Lewis acid. More simply, these metal atoms show a propensity to accept donor electrons. This propensity is even more pronounced with any surface metal ions bearing a positive charge. Analytes with sufficient Lewis base characteristics (any substance that can donate non-bonding electrons) can potentially adsorb to these sites and thus form problematic non-covalent complexes. It is these substances that are defined as metal-interacting analytes.
For example, analytes having phosphate groups are excellent polydentate ligands capable of high affinity metal chelation. This interaction causes phosphorylated species to bind to the flow path metals thus reducing the detected amounts of such species, a particularly troublesome effect given that phosphorylated species are frequently the most important analytes of an assay.
Other characteristics of analytes can likewise pose problems. For example, carboxylate groups also have the ability to chelate to metals, albeit with lower affinities than phosphate groups. Yet, carboxylate functional groups are ubiquitous in, for example, biomolecules, giving the opportunity for cumulative polydentate-based adsorptive losses. These complications can exist not only on peptides and proteins, but also glycans. For example, N-glycan species can at times contain one or more phosphate groups as well as one or more carboxylate containing sialic acid residues. Additionally, smaller biomolecules such as nucleotides and saccharides, like sugar phosphates, can exhibit similar behavior to the previously mentioned N-glycan molecules. Moreover, chromatographic secondary interactions can be especially problematic with biomolecules, particularly larger structures, because they have a capacity (via their size and structural order) to form microenvironments that can adversely interact with separation components and flow path surfaces. In this case, a biomolecule or analyte having larger structures, can present structural regions with chemical properties that amplify a secondary interaction to the material of a flow path. This, combined with the cumulative metal chelation effects curtails the overall effective separation of biomolecules, pesticides, bisphosphonic acids, anionic metabolites, and zwitterions like amino acids and neurotransmitters.
An alternative to using metal flow paths is to use flow paths constructed from polymeric materials, such as polyether ether ketone (PEEK). PEEK tubing, like most polymeric materials, is formed by means of an extrusion process. With polymeric resin, this manufacturing process can lead to highly variable internal diameters. Accordingly, PEEK column hardware yields unfavorable differences in the retention times as can be observed from switching between one column and the next. Often, this variation can be a factor of three higher than a metal constructed column. In addition, the techniques for fabricating polymer based frits are not yet sufficiently optimized to afford suitably rugged components for commercial HPLC columns. For example, commercially available PEEK frits tend to exhibit unacceptably low permeability.
Ongoing efforts to reduce chelation and secondary chromatographic interactions of analytes with metal chromatographic surfaces in an effort to facilitate chromatographic separation having higher resolutions are therefore needed.
One advantage of the alkylsilyl coatings of the present technology is that metal chromatographic flow paths can be used while minimizing the interactions between analytes and the metal flow paths. Coating the flow path of instrumentation and chromatographic devices with certain alklysilyl compositions improves multiple aspects of liquid chromatography separations where the analyte of interest is a metal-interacting analyte. The use of alkylsilyl coatings on metal flow paths allow the use of metal chromatographic flow paths, which are able to withstand high pressures at fast flow rates, while minimizing the secondary chromatographic interactions between the analyte and the metal. Therefore, high pressure components can be manufactured out of stainless steel or other metallic or high pressure material. These components made of high pressure material can then be tailored in that the internal flow paths can be modified with a coating to address the hydrophobicity of the flow path and reduce secondary chromatographic interactions.
Provided herein, therefore, are methods for isolating analytes comprising the use of vapor depositing one or more alklysilyl derivatives to at least one component of a fluidic system to form a bioinert or low-bind coating, and eluting the analyte through the system. Unlike ambient, liquid phase silanization, coatings which are vapor deposited tend to produce, more resilient modifications of substrates with precisely controlled thicknesses. Also, because vapor deposition is a non-line-of-sight process, this leads to a more uniform coating over substrate contours and complex surfaces. This advantage allows for coatings to be applied to flow paths with narrow internal diameters and curved surfaces, therefore addressing the need for increasingly high pressures at increasingly fast flow rates.
Also provided herein are methods of tailoring a fluidic flow path for separation of a sample comprising an analyte that includes infiltrating a vaporized source of one or more alkylsilyl derivatives through the fluidic flow path to form a bioinert (or low-bind) coating and controlling temperature and pressure to deposit a first coating on wetted surfaces of the flow path.
Also provided are methods of tailoring a fluidic flow path for separation of a sample including an analyte comprising assessing the polarity of the analyte, selecting an appropriate alkylsilyl derivative, and adjusting the hydrophobicity of wetted surfaces of the flow path by vapor depositing the appropriate alkylsilyl derivative to form a bioinert, low-bind coating.
Further provided herein are methods of improving baseline returns in a chromatographic system comprising introducing a sample including an analyte into a fluidic system comprising at least one vapor deposited alkylsilyl derivative to form a bioinert, low-bind coating, and eluting the sample through the system.
The disclosed methods can be applied to stainless steel or other metallic flow path components and provides a manufacturing advantage over alternative non-metallic or non-metallic lined components.
In one aspect, the technology includes a chromatographic device for separating analytes in a sample. The device includes a sample injector having a sample injection needle for injecting the sample into the mobile phase, a sample reservoir container in fluid communication with the sample injector, a chromatography column downstream of the sample injector, wherein the chromatography column having fluid connectors, and fluid conduits connecting the sample injector and the chromatography column. Interior surfaces of the fluid conduits, sample injector, sample reservoir container, and chromatography column form a fluidic flow path having wetted surfaces. At least a portion of the wetted surfaces of the fluidic flow path are coated with a alkylsilyl coating, wherein the alkylsilyl coating is inert to at least one of the analytes in the sample. The alkylsilyl coating has the Formula I:
R1, R2, R3, R4, R5, and R6 are each independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, and halo. RA represents a point of attachment to the interior surfaces of the fluidic system. At least one of R1, R2, R3, R4, R5, and R6 is ORA. X is (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20—, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-. The device can include one or more of the following embodiments in any combination thereof.
The alkylsilyl coating can have a contact angle of at least 15°. In some embodiments, the alkylsilyl coating has a contact angle less than or equal to 30° or less than or equal to 90°.
The chromatographic device can also include a detector downstream of the chromatography column. The fluidic flow path can also include the detector. In some embodiments the detector is a mass spectrometer and the fluidic flow path includes wetted surfaces of an electrospray needle.
In some embodiments, the fluidic flow path has a length to diameter ratio of at least 20. The alkylsilyl coating can have a thickness of at least 100 Å.
In some embodiments, X is (C2-C10)alkyl. In other embodiments, X is ethyl. R1, R2, R3, R4, R5, and R6 can each be methoxy or chloro. The alkylsilyl coating of Formula I can be bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane.
In some embodiments, the device also includes a second alkylsilyl coating in direct contact with the alkylsilyl coating of Formula I. The second alkylsilyl coating has the Formula II:
R7, R8, and R9 are each independently selected from —NH(C1-C6)alkyl, —N[(C1-C6)alkyl]2, (C1-C6)alkoxy, (C1-C6)alkyl, (C1-C6)alkenyl, OH, and halo. R10 is selected from (C1-C6)alkyl, —ORB, —[O(C1-C3)alkyl]1-10O(C1-C6)alkyl, —[O(C1-C3)alkyl]1-10OH, and phenyl, wherein said (C1-C6)alkyl is optionally substituted with one or more halo and wherein said phenyl is optionally substituted with one or more groups selected from (C1-C3)alkyl, hydroxyl, fluorine, chlorine, bromine, cyano, —C(O)NH2, and carboxyl. RB is —(C1-C3)alkyloxirane, —(C1-C3)alkyl-3,4-epoxycyclohexyl, or —(C1-C4)alkylOH. The hashed bond to R10 represents an optional additional covalent bond between R10 and the carbon bridging the silyl group to form an alkene, provided y is not 0. y is an integer from 0 to 20.
In some embodiments, y is an integer from 2 to 9. In some embodiments, is 9, R10 is methyl, and R7, R8, and R9 are each ethoxy or chloro.
The alkylsilyl coating of Formula II can be (3-glycidyloxypropyl)trimethoxysilane, n-decyltrichlorosilane, trimethylchlorosilane, trimethyldimethyaminosilane, methoxy-polyethyleneoxy(1-10) propyl trichlorosilane, or methoxy-polyethyleneoxy(1-10) propyl trimethoxysilane. In some embodiments, the alkylsilyl coating of Formula II is (3-glycidyloxypropyl)trimethoxysilane followed by hydrolysis.
The alkylsilyl coating of Formula I and II can provide a desired contact angle of about 0° to about 105°.
In some embodiments, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II is (3-glycidyloxypropyl)trimethoxysilane. The alkylsilyl coating of Formula I can be bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II can be (3-glycidyloxypropyl)trimethoxysilane followed by hydrolysis. In some embodiments, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II is n-decyltrichlorosilane. The alkylsilyl coating of Formula I can be bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II can be trimethylchlorosilane or trimethyldimethyaminosilane. In some embodiments, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II is methoxy-polyethyleneoxy(3)silane.
The chromatographic device can also include an alkylsilyl coating having the Formula III in direct contact with the alkylsilyl coating of Formula I,
R11, R12, R13, R14, R15 and R16 are each independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, and halo. Z is (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20—, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-. In some embodiments, the alkylsilyl coating of Formula III is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane. The alkylsilyl coating of Formula I can be bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula III can be bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane. In some embodiments, the alkylsilyl coating of I and III has a total thickness of about 400 Å.
In another aspect, the technology relates to a method of separating a sample comprising a glycan, a peptide, or a pesticide. The method includes introducing the sample comprising the glycan, the peptide, or the pesticide to a fluidic system including a flow path disposed in an interior of the fluidic system. The flow path comprising a alkylsilyl coating having the Formula I:
R1, R2, R3, R4, R5, and R6 are each independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, and halo. RA represents a point of attachment to the interior surfaces of the fluidic system. At least one of R1, R2, R3, R4, R5, and R6 is ORA. X is (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20—, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-. A second alkylsilyl coating is in direct contact with the alkylsilyl coating of Formula I. the second alkylsilyl coating has the Formula II:
R7, R8, and R9 are each independently selected from —NH(C1-C6)alkyl, —N[(C1-C6)alkyl]2, (C1-C6)alkoxy, (C1-C6)alkyl, (C1-C6)alkenyl, OH, and halo. R10 is selected from (C1-C6)alkyl, —ORB, —[O(C1-C3)alkyl]1-10O(C1-C6)alkyl, —[O(C1-C3)alkyl]1-10OH, and phenyl. (C1-C6)alkyl is optionally substituted with one or more halo. The phenyl is optionally substituted with one or more groups selected from (C1-C3)alkyl, hydroxyl, fluorine, chlorine, bromine, cyano, —C(O)NH2, and carboxyl.
RB is —(C1-C3)alkyloxirane, —(C1-C3)alkyl-3,4-epoxycyclohexyl, or —(C1-C4)alkylOH. The hashed bond to R10 represents an optional additional covalent bond between R10 and the carbon bridging the silyl group to form an alkene, provided y is not 0. y is an integer from 0 to 20. The method also includes eluting the sample through the fluidic system, thereby isolating the glycan, the peptide or the pesticide. The method can include one or more of the embodiments described herein in any combination thereof.
In some embodiments, the flow path is defined at least in part by the interior surface of a chromatographic column. The flow path can be further defined at least in part by passageways through a frit of the chromatographic column. In some embodiments, the flow path is further defined at least in part by interior surfaces of tubing. The flow path can be formed of stainless steel
In some embodiments, the glycan is a phosphoglycan. The peptide can be a phosphopeptide. The pesticide can be glyphosate.
In some embodiments, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane. The alkylsilyl coating of Formula II can be n-decyltrichlorosilane. In some embodiments, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II is n-decyltrichlorosilane.
In another aspect, the technology includes a method of separating a sample comprising a citric acid cycle metabolite. The method includes introducing the sample comprising the citric acid cycle metabolite to a fluidic system including a flow path disposed in an interior of the fluidic system. The flow path includes a alkylsilyl coating has the Formula I:
R1, R2, R3, R4, R5, and R6 are each independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, and halo. RA represents a point of attachment to the interior surfaces of the fluidic system. At least one of R1, R2, R3, R4, R5, and R6 is ORA. X is (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20—, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-; A second alkylsilyl coating is in direct contact with the alkylsilyl coating of Formula I. The second alkylsilyl coating has the Formula II:
R7, R8, and R9 are each independently selected from —NH(C1-C6)alkyl, —N[(C1-C6)alkyl]2, (C1-C6)alkoxy, (C1-C6)alkyl, (C1-C6)alkenyl, OH, and halo. R10 is selected from (C1-C6)alkyl, —ORB, —[O(C1-C3)alkyl]1-10O(C1-C6)alkyl, —[O(C1-C3)alkyl]1-10OH, and phenyl. The (C1-C6)alkyl is optionally substituted with one or more halo. The phenyl is optionally substituted with one or more groups selected from (C1-C3)alkyl, hydroxyl, fluorine, chlorine, bromine, cyano, —C(O)NH2, and carboxyl. RB is —(C1-C3)alkyloxirane, —(C1-C3)alkyl-3,4-epoxycyclohexyl, or —(C1-C4)alkylOH. The hashed bond to R10 represents an optional additional covalent bond between R10 and the carbon bridging the silyl group to form an alkene, provided y is not 0. y is an integer from 0 to 20. The method also includes eluting the sample through the fluidic system, thereby isolating the citric acid cycle metabolite. The method can include one or more of the embodiments described herein in any combination thereof.
In some embodiments, the flow path is defined at least in part by the interior surface of a chromatographic column. The flow path can be further defined at least in part by passageways through a frit of the chromatographic column. The flow path can be further defined at least in part by interior surfaces of tubing. The citric acid cycle metabolite can be citric acid or malic acid.
In some embodiments, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane. The alkylsilyl coating of Formula II can be trimethylchlorosilane or trimethyldimethyaminosilane. In some embodiments, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II is trimethylchlorosilane or trimethyldimethyaminosilane.
In another aspect, the technology includes a method of tailoring a fluidic flow path for separation of a sample. The method includes assessing a polarity of an analyte in the sample, selecting a chromatographic media based on the analyte in the sample, and selecting a alkylsilyl coating based on the polarity of the analyte in the sample. The alkylsilyl coating is inert to the analyte in the sample. The alkylsilyl coating has the Formula I:
R1, R2, R3, R4, R5, and R6 are each independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, and halo. RA represents a point of attachment to wetted surfaces of the fluidic flow path. At least one of R1, R2, R3, R4, R5, and R6 is ORA. X is (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20—, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-. The method also includes adjusting a hydrophobicity of the wetted surfaces of the fluidic flow path by vapor depositing the alkylsilyl coating onto the wetted surfaces of the fluidic flow path. The method can include one or more of the embodiments described herein in any combination thereof.
In some embodiments, the analyte in the sample is retained with a retentivity within 10% of the retentivity attributable to the chromatography media. In some embodiments, the analyte in the sample is retained with a retentivity within 5% of the retentivity attributable to the chromatographic media. In some embodiments, the analyte in the sample is retained with a retentivity within 1% of the retentivity attributable to the chromatographic media.
The alkylsilyl coating can provide a desired contact angle of about 0° or about 95°.
In some embodiments, the wetted surface of the fluidic flow path are defined at least in part by an interior surface of a column or an interior surface of a sample injection needle. The wetted surface of the fluidic flow path can extend from an interior surface of a sample injection needle through the interior surface of a column. In some embodiments, the wetted surface of the fluidic flow path extends from a sample reservoir container disposed upstream of an in fluidic communication with an interior surface of a sample injection needle throughout the fluidic system to a connector or port of a detector.
The detector can be a mass spectrometer and the wetted surface of the fluidic flow path includes an interior surface of an electrospray needle.
In some embodiments, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane.
The method can also include annealing the alkylsilyl coating after vapor depositing the alkylsilyl coating onto the wetted surfaces of the fluidic flow path.
In some embodiments, the method also includes modifying the alkylsilyl coating of Formula I with a silanizing reagent to obtain a desired thickness of the alkylsilyl coating. The silanizing reagent can be a non-volatile zwitterion. The non-volatile zwitterion can be sulfobetaine or carboxybetaine. The silianizing reagent can be an acidic or basic silane. In some embodiments, the silanizing agent is methoxy-polyethyleneoxy(6-9)silane.
In some embodiments, the method also includes adjusting the hydrophobicity of the wetted surfaces of the fluidic flow path by vapor depositing a second alkylsilyl coating in direct contact with the vapor deposited alkylsilyl coating of Formula I. The second alkylsilyl coating has the Formula II:
R7, R8, and R9 are each independently selected from —NH(C1-C6)alkyl, —N[(C1-C6)alkyl]2, (C1-C6)alkoxy, (C1-C6)alkyl, (C1-C6)alkenyl, OH, and halo. R10 is selected from (C1-C6)alkyl, —ORB, —[O(C1-C3)alkyl]1-10O(C1-C6)alkyl, —[O(C1-C3)alkyl]1-10OH, and phenyl, wherein said (C1-C6)alkyl is optionally substituted with one or more halo and wherein said phenyl is optionally substituted with one or more groups selected from (C1-C3)alkyl, hydroxyl, fluorine, chlorine, bromine, cyano, —C(O)NH2, and carboxyl/RB is —(C1-C3)alkyloxirane, —(C1-C3)alkyl-3,4-epoxycyclohexyl, or —(C1-C4)alkylOH. The hashed bond to R10 represents an optional additional covalent bond between R10 and the carbon bridging the silyl group to form an alkene, provided y is not 0. y is an integer from 0 to 20.
In some embodiments, the alkylsilyl coating of Formula II is (3-glycidyloxypropyl)trimethoxysilane, n-decyltrichlorosilane, trimethylchlorosilane, trimethyldimethyaminosilane, or methoxy-polyethyleneoxy(3)silane. The alkylsilyl coating of Formula II can be (3-glycidyloxypropyl)trimethoxysilane followed by hydrolysis.
In some embodiments, the alkylsilyl coating of Formula I and II provides a desired contact angle of about 0° to about 105°.
The method can also include modifying the alkylsilyl coating of Formula II with a silanizing reagent to obtain a desired thickness of the alkylsilyl coating. The silanizing reagent can be a non-volatile zwitterion. The non-volatile zwitterion can be sulfobetaine or carboxybetaine. The silianizing reagent can be an acidic or basic silane. In some embodiments, the silanizing agent is methoxy-polyethyleneoxy(6-9)silane.
In some embodiments, the analyte is a biomolecule. The biomolecule is a peptide or peptide fragment, an oligopeptide, a protein, a glycan, a nucleic acid or nucleic acid fragment, a growth factor, a carbohydrate, a fatty acid or a lipid. The analyte can be a citric acid cycle metabolite. In some embodiments, the analyte is a pesticide.
The method can also include assessing a polarity of the chromatographic media and selecting the alkylsilyl coating based on the polarity of the analyte and the chromatographic media.
In some embodiments, the also includes eluting the sample through the fluidic flow path, thereby isolating the analyte.
In another aspect, the technology includes a method of tailoring a fluidic flow path for separation of a sample. The method includes infiltrating a vaporized source of an alkylsilyl of Formula III on wetted surfaces of the fluidic flow path
R11, R12, R13, R14, R15, and R16 are each independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, and halo. Z is (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20—, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-. The method also includes controlling temperature and pressure to deposit a first coating of Formula III on the wetted surfaces of the fluidic flow path, the first coating having a thickness of at least 100 Å and a contact angle of at least 15°. The method can include one or more of the embodiments described herein in any combination thereof.
In some embodiments, the method also includes pretreating the wetted surfaces of the fluidic flow path with a plasma prior to depositing the first coating of Formula III.
The method can also include modifying the alkylsilyl coating of Formula III with a silanizing reagent to obtain a desired thickness of the alkylsilyl coating. The silanizing reagent can be a non-volatile zwitterion. The non-volatile zwitterion can be sulfobetaine or carboxybetaine. The silianizing reagent can be an acidic or basic silane. In some embodiments, the silanizing agent is methoxy-polyethyleneoxy(6-9)silane.
In general, a number of aspects of the technology are directed to (1) devices having an alkylsilyl coating; (2) methods of tailoring or tuning a flow path for isolation of an analyte, in particular a metal-interacting analyte; (3) method of isolating an analyte in a sample, in particular a metal-interacting analyte; and (4) kits comprising various chromatographic components coated with an alkylsilyl coating and instructions for use. In some aspects, a bioinert, low-bind coating is used to modify a flow path to address flow path interactions with an analyte. That is, the bioinert, low-bind coating minimizes surface reactions with the metal interacting analyte and allows the analyte to pass along a flow path without clogging, attaching to surfaces, or change in analyte properties. The reduction/elimination of these interactions is advantageous because it allows for accurate quantification and analysis of a sample containing a metal-interacting analyte, for example biomolecules, proteins, glycans, peptides, oligonucleotides, pesticides, bisphosphonic acids, anionic metabolites, and zwitterions like amino acids and neurotransmitters. The biomolecule can be selected from a peptide or peptide fragment, an oligopeptide, a protein, a glycan, a nucleic acid or nucleic acid fragment, a growth factor, a carbohydrate, a fatty acid, and a lipid. In one aspect, the biomolecule is a protein, a peptide, or a glycan. The biomolecule can be a phosphoglycan or a phosphopeptide.
In the present technology, vapor deposited alkylsilyl coatings on wetted surfaces of fluidic systems (e.g., liquid chromatography systems) modify the fluidic path and decrease secondary interactions. As such, they are bioinert or low-bind (meaning that analytes of a sample do not interact, or have minimal interaction, with the alkylsilyl coating). In addition, the deposited coatings are highly tunable to provide a range of desirable contact angles (e.g., make the wetted surfaces hydrophilic or hydrophobic), chemistries, and properties to achieve a desired effect on the flow path and ultimately the sample passing through the flow path.
Devices
The detector 150, can be a mass spectrometer. The fluidic flow path can include wetted surfaces of an electrospray needle (not shown).
At least a portion of the wetted surfaces can be coated with an alkyl silyl coating, described in detail herein, to tailor its hydrophobicity. The coating can be applied by vapor deposition. As such, methods and devices of the present technology provide the advantage of being able to use high pressure resistant materials (e.g., stainless steel) for the creation of the flow system, but also being able to tailor the wetted surfaces of the fluidic flow path to provide the appropriate hydrophobicity so deleterious interactions or undesirable chemical effects on the sample can be minimized.
The alkylsilyl coating can be provided throughout the system from the tubing or fluid conduits 110 extending from the fluid manager system 105 all the way through to the detector 150. The coatings can also be applied to portions of the fluidic fluid path. That is, one may choose to coat one or more components or portions of a component and not the entire fluidic path. For example, the internal portions of the column 125 and its frits 120 and end caps 115 can be coated whereas the remainder of the flow path can be left unmodified. Further, removable/replaceable components can be coated. For example, the vial or sinker 130 containing the sample reservoir can be coated as well as frits 120.
In one aspect, the flow path of the fluidic systems described herein is defined at least in part by an interior surface of tubing. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by an interior surface of microfabricated fluid conduits. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by an interior surface of a column. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by passageways through a frit. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by an interior surface of a sample injection needle. In another aspect, the flow path of the fluidic systems described herein extends from the interior surface of a sample injection needle throughout the interior surface of a column. In another aspect, the flow path extends from a sample reservoir container (e.g. sinker) disposed upstream of and in fluidic communication with the interior surface of a sample injection needle throughout the fluidic system to a connector/port to a detector.
In some embodiments, only the wetted surfaces of the chromatographic column and the components located upstream of the chromatographic column are coated with the alkylsilyl coatings described herein while wetted surfaces located downstream of the column are not coated. The coating can be applied to the wetted surfaces via vapor deposition.
At least a portion of the wetted surfaces of the fluidic flow path are coated with an alkylsilyl coating. The alkylsilyl coating is inert to at least one of the analytes in the sample. The alkylsilyl coating can have the Formula I:
R1, R2, R3, R4, R5, and R6 are each independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, and halo (i.e., a halogen, for example chloro). RA represents a point of attachment to the interior surfaces of the fluidic system. At least one of R1, R2, R3, R4, R5, and R6 is ORA. X is (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20—, or —(C1-C10) [alkylphenyl(C1-C10)alkyl]1-20-.
When used in the context of a chemical formula, a hyphen (“-”) indicates the point of attachment. For example, when X is —[(C1-C10)alkylphenyl(C1-C10)alkyl]1-20-, that means that X is connected to SiR1R2R3 via the (C1-C10)alkyl and connected to SiR4R5R6 via the other (C1-C10)alkyl. This applies to the remaining variables.
In one aspect, X in Formula I is (C1-C15)alkyl, (C1-C12)alkyl, or (C1-C10)alkyl. In some aspects, X in Formula I is methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, iso-butyl, t-butyl, pentyl, hexyl, heptyl, nonyl, or decanyl. In other aspect, X in Formula I is ethyl or decanyl.
In one aspect, at least one of R1, R2, R3, R4, R5, and R6 is (C1-C6)alkoxy, e.g., ethoxy, wherein the values for X are described in Formula I or the preceding paragraph. In another aspect, at least two of R1, R2, R3, R4, R5, and R6 is (C1-C6)alkoxy, e.g., ethoxy, wherein the values for X are described in Formula I or the preceding paragraph. In another aspect, at least three of R1, R2, R3, R4, R5, and R6 is (C1-C6)alkoxy, e.g., ethoxy, wherein the values for X are described in Formula I or the preceding paragraph. In another aspect, at least four of R1, R2, R3, R4, R5, and R6 is (C1-C6)alkoxy, e.g., ethoxy, wherein the values for X are described in Formula I or the preceding paragraph. In another aspect, at least five of R1, R2, R3, R4, R5, and R6 is (C1-C6)alkoxy, e.g., ethoxy, wherein the values for X are described in Formula I or the preceding paragraph.
In one aspect, at least one of R1, R2, R3, R4, R5, and R6 is halo, e.g., chloro, wherein the values for X are described in Formula I or the preceding paragraphs above. In another aspect, at least two of R1, R2, R3, R4, R5, and R6 is halo, e.g., chloro, wherein the values for X are described in Formula I or the preceding paragraphs above. In another aspect, at least three of R1, R2, R3, R4, R5, and R6 is halo, e.g., chloro, wherein the values for X are described in Formula I or the preceding paragraphs above. In another aspect, at least four of R1, R2, R3, R4, R5, and R6 is halo, e.g., chloro, wherein the values for X are described in Formula I or the preceding paragraphs above. In another aspect, at least five of R1, R2, R3, R4, R5, and R6 is halo, e.g., chloro, wherein the values for X are described in Formula I or the preceding paragraphs above.
In another aspect, R1, R2, R3, R4, R5, and R6 are each methoxy or chloro.
The alkylsilyl coating of Formula I can have a contact angle of at least about 15°. In some embodiments, the alkylsilyl coating of Formula I can have a contact angle of less than or equal to 30°. The contact angle can be less than or equal to about 90°. In some embodiments, the contact angle of the alkylsilyl coating of Formula I is between about 15° to about 105°. For example, the contact angle of the alkylsilyl coating of Formula I can be about 0°, 5°, 10°, 15°, 20°, 25°, 30°, 35°, 40°, 45°, 50°, 55°, 60°, 65°, 70°, 75°, 80°, 85°, 90°, 95°, 100°, or 105°.
The thickness of the alkylsilyl coating can be at least about 100 Å. For example the thickness can be between about 100 Å to about 1600 Å. The thickness of the alkylsilyl coating for Formal I can be about 100 Å, 200 Å, 300 Å, 400 Å, 500 Å, 600 Å, 700 Å, 800 Å, 900 Å, 1000 Å, 1100 Å, 1200 Å, 1300 Å, 1400 Å, 1500 Å or 1600 Å. The thickness of the alkylsilyl coating (e.g., a vapor deposited alkylsilyl coating) can be detected optically by the naked eye. For example, more opaqueness and coloration is indicative of a thicker coating. Thus, coatings with pronounced visual distinction are an embodiment of this technology. From thin to thick, the color changes from yellow, to violet, to blue, to slightly greenish and then back to yellow when coated parts are observed under full-spectrum light, such as sunlight. For example, when the alkylsilyl coating is 300 Å thick, the coating can appear yellow and reflect light with a peak wavelength between 560 and 590 nm. When the alkylsilyl coating is 600 Å thick, the coating can appear violet and reflect light with a peak wavelength between 400 and 450 nm. When the alkylsilyl coating is 1000 Å thick, the coating can appear blue and reflect light with a peak wavelength between 450 and 490 nm. See, e.g., Faucheu et al., Relating Gloss Loss to Topographical Features of a PVDF Coating, Published Oct. 6, 2004; Bohlin, Erik, Surface and Porous Structure of Pigment Coatings, Interactions with flexographic ink and effects of print quality, Dissertation, Karlstad University Studies, 2013:49.
In one aspect, the vapor deposited coating of Formula I is the product of vapor deposited bis(trichlorosilyl)ethane, bis(trimethoxysilyl)ethane, bis(trichlorosilyl)octane, bis(trimethoxysilyl)octane, bis(trimethoxysilyl)hexane, and bis(trichlorosilyl)hexane.
In some aspects, at least a portion of the wetted surfaces of the fluidic flow path are coated with multiple layers of the same or different alkysilyls, where the thickness of the alkylsilyl coatings correlate with the number of layering steps performed (e.g., the number of deposited layers of alkylsilyl coating on wetted surface of the fluidic flow path of the chromatographic system/device). In this manner, increasingly thick bioinert coatings can be produced and tailored to achieve desirable separations.
The chromatographic device can have a second alkylsilyl coating in direct contact with the alkylsilyl coating of Formula I. The second alkylsilyl coating has the Formula II
wherein R7, R8, and R9 are each independently selected from —NH(C1-C6)alkyl, —N[(C1-C6)alkyl]2, (C1-C6)alkoxy, (C1-C6)alkyl, (C1-C6)alkenyl, OH, and halo; R10 is selected from (C1-C6)alkyl, —ORB, [O(C1-C3)alkyl]1-10O(C1-C6)alkyl, —[O(C1-C3)alkyl]1-10OH and phenyl. (C1-C6)alkyl is optionally substituted with one or more halo. The phenyl is optionally substituted with one or more groups selected from (C1-C3)alkyl, hydroxyl, fluorine, chlorine, bromine, cyano, —C(O)NH2, and carboxyl. RB is —(C1-C3)alkyloxirane, —(C1-C3)alkyl-3,4-epoxycyclohexyl, or —(C1-C4)alkylOH. The hashed bond to R10 represents an optional additional covalent bond between R10 and the carbon bridging the silyl group to form an alkene, provided y is not 0. y is an integer from 0 to 20.
In one aspect, y in Formula II is an integer from 1 to 15. In another aspect, y in Formula II is an integer from 1 to 12. In another aspect, y in Formula II is an integer from 1 to 10. In another aspect, y in Formula II is an integer from 2 to 9.
In one aspect R10 in Formula II is methyl and y is as described above for Formula II or the preceding paragraph.
In one aspect, R7, R8, and R9 in Formula II are each the same, wherein R10 and y are as described above. In one aspect, R7, R8, and R9 are each halo (e.g., chloro) or (C1-C6)alkoxy such as methoxy, wherein R10 and y are as described above.
In one aspect, y in Formula II is 9, R10 is methyl, and R7, R8, and R9 are each ethoxy or chloro.
In one aspect, the coating of the formula II is n-decyltrichlorosilane, (3-glycidyloxypropyl)trimethoxysilane (GPTMS), (3-glycidyloxypropyl)trimethoxysilane (GPTMS) followed by hydrolysis, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, trimethylchlorosilane, trimethyldimethyaminosilane, methoxy-polyethyleneoxy(3)silane propyltrichlorosilane, propyltrimethoxysilane, (heptadecafluoro-1,1,2,2-tetrahydrodecyl)tris(dimethylamino)silane, (heptadecafluoro-1,1,2,2-tetrahydrodecyl)trischlorosilane, (heptadecafluoro-1,1,2,2-tetrahydrodecyl)trimethoxysilane vinyltrichlorosilane, vinyltrimethoxysilane, allyltrichlorosilane, 2-[methoxy(polyethyleneoxy)3propyl]trichlorosilane, 2-[methoxy(polyethyleneoxy)3propyl]trimethoxysilane, or 2-[methoxy(polyethyleneoxy)3propyl]tris(dimethylamino)silane.
The alkylsilyl coating of Formula I and II can have a contact angle of at least about 15°. In some embodiments, the alkylsilyl coating of Formula I and II can have a contact angle of less than or equal to 105°. The contact angle can be less than or equal to about 90°. In some embodiments, the contact angle of the alkylsilyl coating of Formula I and II is between about 15° to about 105°. For example, the contact angle of the alkylsilyl coating of Formula I and II can be about 0°, 5°, 10°, 15°, 20°, 25°, 30°, 35°, 40°, 45°, 50°, 55°, 60°, 65°, 70°, 75°, 80°, 85°, 90°, 95°, 100°, or 105°.
The thickness of the multi-layered alkylsilyl coating can be at least about 100 Å. For example the thickness can be between about 100 Å to about 1600 Å. The thickness of the multi-layered alkylsilyl coating for Formal I can be about 100 Å, 200 Å, 300 Å, 400 Å, 500 Å, 600 Å, 700 Å, 800 Å, 900 Å, 1000 Å, 1100 Å, 1200 Å, 1300 Å, 1400 Å, 1500 Å or 1600 Å.
In one aspect, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II is (3-glycidyloxypropyl)trimethoxysilane. In another aspect, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II is (3-glycidyloxypropyl)trimethoxysilane followed by hydrolysis. In one aspect, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II is n-decyltrichlorosilane. The alkylsilyl coating of Formula I can be bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II can be trimethylchlorosilane or trimethyldimethyaminosilane. In one aspect, the alkylsilyl coating of Formula I is bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II is methoxy-polyethyleneoxy(3) propyl tricholorosilane or methoxy-polyethyleneoxy(3) propyl trimethoxysilane.
The chromatographic device can have an alkylsilyl coating in direct contact with the alkylsilyl coating of Formula III in direct contact with the alkylsilyl coating of Formula I.
R11, R12, R13, R14, R15, and R16 are each independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, and halo (i.e., a halogen, for example, chloro). Z is (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20—, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-. In some aspects, Z in Formula III is (C1-C10)alkyl; and R1, R2, R3, R4, R5, and R6 are each methoxy or chloro. In other aspects, Z in Formula III is (C2-C10)alkyl. In other aspects, Z in Formula III is ethyl.
In the layered alkylsilyl coating of Formula I and Formula III, Formula I and Formula III can be the same (for example, C2C2) or Formula I and Formula III can be different. Formula III is attached directly to the coating of Formula I, i.e., in Formula III, there is no point of attachment to the interior of the fluidic system; instead Formula III is deposited directly on Formula I.
The alkylsilyl coating of Formula III can be bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane. The alkylsilyl coating of Formula I can be bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula III can be bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane.
The alkylsilyl coating of Formula I and III can have a contact angle of at least about 15°. In some embodiments, the alkylsilyl coating of Formula I and III can have a contact angle of less than or equal to 105°. The contact angle can be less than or equal to about 90°. In some embodiments, the contact angle of the alkylsilyl coating of Formula I and III is between about 15° to about 105°. For example, the contact angle of the alkylsilyl coating of Formula I and III can be about 0°, 5°, 10°, 15°, 20°, 25°, 30°, 35°, 40°, 45°, 50°, 55°, 60°, 65°, 70°, 75°, 80°, 85°, 90°, 95°, 100°, or 105°.
The thickness of the multi-layered alkylsilyl coating can be at least about 100 Å. For example the thickness can be between about 100 Å to about 1600 Å. The thickness of the multi-layered alkylsilyl coating for Formal I can be about 100 Å, 200 Å, 300 Å, 400 Å, 500 Å, 600 Å, 700 Å, 800 Å, 900 Å, 1000 Å, 1100 Å, 1200 Å, 1300 Å, 1400 Å, 1500 Å or 1600 Å.
In one aspect, the alkylsilyl coating of Formula II is applied directly to wetted surfaces of the fluidic flow path. Therefore, in some embodiments, one of R7, R8, and R9 of Formula II can also include ORA, where RA represents a point of attachment to the interior surfaces (e.g., wetted surfaces) of the fluidic system. In other embodiments, R7, R8, and R9 of the alkylsilyl coating of Formula II does not include ORA, by the alkylsilyl coating of Formula II is deposited directly onto wetted surfaces of the fluidic flow path that have been pre-treated with, for example, a plasma.
In one aspect, stainless steel flow path components, including but not limited to tubing, microfabricated fluid conduits, column frits, column inlet tubing, and sample injection needles, are coated via vapor deposition with one or more of the disclosed alkylsilyls. In one aspect, these coated components are annealed to alter their chemical or physical properties.
In another aspect, flow path components that are made of other materials than stainless steel or other metallics, (e.g., polymers, glass, etc.) are coated via vapor deposition with one or more of the disclosed alkylsilyls. In particular, frits for use within the system or sample vials connectable to the injection needle are coated.
Exemplary coatings with their respective approximate thickness and contact angle are provided in Table 1.
Referring to VPD #1 (C2-GPTMS-OH), the first coating layer, C2 shown below, is a layer according to Formula I, described above.
The second layer of VPD #1, GPTMS-OH, shown below, is a layer according to Formula II.
VPD #3 (C2-C2) is an example of a coating of Formula I and then a coating for Formula III.
VPD #7 (C2C10) is another example of a coating of Formula I and a second layer of Formula II. The structure of bis(trichlorosilyl)ethane or bis(trismethoxysilyl)ethane (C2) is shown above. The structure of C10 is shown below.
VPD #11 (C2C3) is another example of a coating of Formula I and a second layer of Formula II. The structure of bis(trichlorosilyl)ethane or bis(trismethoxysilyl)ethane (C2) is shown above. The structure of C3 is shown below.
VPD #13 is another example of a coating of Formula I and a second layer of Formula II. The structure of bis(trichlorosilyl)ethane or bis(trismethoxysilyl)ethane (C2) is shown above. The structure of methoxy-polyethyleneoxy(3)propyl trichlorosilane (PEO) is shown below.
Alternatively, commercially available vapor deposition coatings can be used in the disclosed systems, devices, and methods, including but not limited to Dursan® (commercially available from SikcoTek Corporation, Bellefonte, Pa.).
In one aspect, the alkylsilyl coatings described herein enhance the corrosion performance of metals, e.g., as in metallic chromatography columns. Depending on the denseness and thickness, the coatings act as a barrier, thereby preventing water and corrosive molecules from reacting with the base metal. While increasing the hydrophobicity and density improves the corrosion performance, even coatings derived from C2 and GPTMS (C2-GPTMS) followed by hydrolysis to form C2-GPTMS-OH shows a 10× improvement in the ASTM G48 Method A pitting corrosion, see e.g., Example 4 below. In terms of most corrosion resistant to least, the ranking is the material formed from VPD #7>2>1 (bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane as a first layer followed by GPTMS then hydrolysis to form GPTMS-OH as a second layer). This also correlates to hydrophobicity rankings.
Methods of Tailoring a Fluidic Flow Path
The coatings described above can be used to tailor a fluidic flow path of a chromatography system for the separation of a sample. The coatings can be vapor deposited. In general, the deposited coatings can be used to adjust the hydrophobicity of internal surfaces of the fluidic flow path that come into contact with a fluid (i.e. wetted surfaces or surfaces coming into contact with the mobile phase and/or sample/analyte). By coating wetted surfaces of one or more components of a flow path within a chromatography system, a user can tailor the wetted surfaces to provide a desired interaction (or lack of interaction) between the flow path and fluids therein (including any sample, such as biomolecules, proteins, glycans, peptides, oligonucleotides, pesticides, bisphosphonic acids, anionic metabolites, and zwitterions like amino acids and neurotransmitters, within the fluid).
In one aspect, an effective coating is produced from a low temperature, vacuum-assisted vapor deposition process. In one aspect, an oxygen plasma pretreatment step precedes the coating deposition. The oxygen plasma removes organic compounds and improves surface wettability for the coatings. Time, temperature, and pressure are controlled for each processing step. Each coating run can use a silicon wafer to monitor the thickness and contact angle of the resultant coating. Ellipsometry can be used to measure the coating thickness, and an optical goniometer can be used to measure the contact angle of the coating. A post coating annealing step can be utilized to increase coating cross-linking and increase coating hydrophobicity.
Next, an infiltration step (210) is initiated. A vaporized source of an alkylsilyl compound (e.g., the alkylsilyl compounds of Formulas I, II and/or III) is infiltrated into the flow path. The vaporized source is free to travel throughout and along the internal surfaces of the flow path. Temperature and/or pressure is controlled during infiltration such that the vaporized source is allowed to permeate throughout the internal flow path and to deposit a coating from the vaporized source on the exposed surface (e.g., wetted surfaces) of the flow path as shown in step 215. Additional steps can be taken to further tailor the flow path. For example, after the coating is deposited, it can be heat treated or annealed (step 220) to create cross linking within the deposited coating and/or to adjust the contact angle or hydrophobicity of the coating. Additionally or alternatively, a second coating of alkylsilyl compound (having the same or different form) can be deposited by infiltrating a vaporized source into the flow path and depositing a second or additional layers in contact with the first deposited layer as shown in step 225. After the deposition of each coating layer, an annealing step can occur. Numerous infiltration and annealing steps can be provided to tailor the flow path accordingly (step 230).
A method of tailoring a fluidic flow path for separation of a sample is provided that includes assessing a polarity of an analyte in the sample and selecting a chromatographic media based on the analyte in the sample. An alkylsilyl coating is selected based on the polarity of the analyte in the sample. The alkylsilyl coating is selected so that the coating is inert to the analyte(s) being separated. In other words, the alkylsilyl coating does not produce any secondary chromatographic effects that are attributable to the alkylsilyl coating. In some embodiments, the analyte is a biomolecule. The biomolecule can be a peptide or peptide fragment, an oligopeptide, a protein, a glycan, a nucleic acid or nucleic acid fragment, a growth factor, a carbohydrate, a fatty acid or a lipid. The analyte can be a citric acid cycle metabolite. The analyte can be a pesticide.
The alkylsilyl coating can have the Formula I, II, or III as described above. In one embodiment, the alkylsilyl coating has the Formula I as a first layer and Formula II as a second layer. In some embodiments, there is only a single layer coating having Formula I (e.g., bis(trichlorosilyl)ethane or bis(trimethoxysilyl)eithane). In some embodiments, there is only a single layer coating having Formula II (e.g., (3-glycidyloxypropyl)trimethoxysilane, n-decyltrichlorosilane, trimethylchlorosilane, trimethyldimethyaminosilane, or methoxy-polyethyleneoxy(3)silane). In some embodiments, there is only a single layer coating having Formula III (e.g., bis(trichlorosilyl)ethane or bis(trimethoxysilyl)eithane).
The method also includes adjusting a hydrophobicity of the wetted surfaces of the fluidic flow path by vapor depositing the alkylsilyl coating onto the wetted surfaces of the fluidic flow path. In some embodiments, the hydrophobicity of the wetted surfaces is adjusted by adjusting the contact angle of the alkylsilyl coating. For example, the contact angle of the alkylsilyl coating can be between about 0° to about 105°.
The analyte in the sample can be retained with a retentivity within 10% of the retentivity attributable to the chromatography media. In some embodiments, the sample can be retained with a retentivity within 5% or within 1% of the retentivity attributable to the chromatography media. Therefore, the alkylsilyl coating solves the problem of metal interaction between the analyte and the metal chromatographic materials without introducing any secondary reactions that would have a negative effect on the quality of the separation. The alkylsilyl coating does not impart any retention mechanism on the analyte of interest, making the coating inert to the analyte of interest and low-bind.
In addition, the alkylsilyl coating does not produce any changes to peak width. The analyte in the sample has a peak width that is within 10%, 5%, or 1% of the peak width attributable to the chromatographic media.
The wetted surfaces of the fluidic flow path can be any of those described above with respect to aspects and embodiments of the chromatographic device.
The method can also include annealing the alkylsilyl coating after vapor depositing the alkylsilyl coating on the wetted surfaces of the fluidic flow path. Typically, the annealing cycle involves subjecting the coating to 200° C. for 3 hours under vacuum.
The method can also include assessing the polarity of the chromatographic media and selecting the alkylsilyl coating based on the polarity of the analyte and the chromatographic media. The method can also include eluting the sample through the fluidic flow path, thereby isolating the analyte.
In some embodiments, the alkylsilyl coating is modified with a silanizing reagent to obtain a desired thickness of the alkylsilyl coating. The silanizing reagent can be a non-volatile zwitterion. The non-volatile zwitterion can be sulfobetaine or carboxybetaine. In some embodiments, the silanizing reagent is an acidic or basic silane. The silanizing reagent can introduce polyethylene oxide moieties, such as methoxy-polyethyleneoxy(6-9)silane, the structure of which is shown below.
In some aspects, the method of tailoring a fluidic flow path for separation of a sample including a biomolecule further comprises: pretreating the wetted surfaces of the flow path with a plasma prior to depositing the first coating. In other aspects, the method of tailoring a fluidic flow path for separation of a sample including a metal interacting analyte further comprises annealing the first coating at a temperature to increase cross-linking in the first coating. In yet another aspect, the method of tailoring a fluidic flow path for separation of a sample including a metal interacting analyte further comprises annealing the first coating at a temperature to alter hydrophobicity.
In one aspect, the method of tailoring a fluidic flow path for separation of a sample including a metal interacting analyte further comprises performing a second infiltration with a vaporized source having the Formula II, wherein the features for Formula II are as described above; along and throughout the interior flow path of the fluidic system to form a second coating deposited in direct contact with the first coating. In one aspect, the step of performing a second infiltration in the preceding method further comprises performing an annealing step after depositing the second coating. In another aspect, the preceding method further comprises connecting in fluid communication with the flow path at least one coated component selected from the group consisting of a sample reservoir container and a frit.
Also provided herein is a method of tailoring a fluidic flow path for separation of a sample including a metal interacting analyte, the method comprising: assessing polarity of the analyte in the sample; selecting an alkylsilyl coating having the Formula I, wherein the features for Formula I are as described above, and desired contact angle based on polarity assessment; and adjusting the hydrophobicity of wetted surfaces of the flow path by vapor depositing an alkylsilyl having the Formula III, wherein the features for Formula III are as described above, and providing the desired contact angle. In some embodiments of the above method, in addition to assessing polarity of the analyte in the sample, the polarity of a stationary phase disposed within at least a portion of the flow path is also assessed and the polarity assessment is obtained from both the polarity of the biomolecule in the sample and the stationary phase.
Methods of Isolating an Analyte
In one aspect, provided herein are methods of isolating an analyte. The method includes introducing a sample including a glycan, a peptide, a pesticide, or a citric acid cycle metabolite into a fluidic system including a flow path disposed in an interior of the fluidic system. The flow path includes a first vapor deposited alkylsilyl inert coating having the Formula I described above and a second vapor deposited coating of the Formula II described above. The sample is eluted through the fluidic system, thereby isolating the glycan, peptide, pesticide, or citric acid cycle metabolite.
The glycan can be a phosphoglycan. The peptide can be a phosphopeptide and the pesticide can be glyphosate. The citric acid cycle metabolite can be citric acid or malic acid.
When the analyte is a glycan, peptide or pesticide, the alkylsilyl coating of Formula I can be bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II can be n-decyltrichlorosilane. When the analyte is a citric acid cycle metabolite, the alkylsilyl coating of Formula I can be bis(trichlorosilyl)ethane or bis(trimethoxysilyl)ethane and the alkylsilyl coating of Formula II can be trimethylchlorosilane or trimethyldimethyaminosilane.
The flow path can be defined at least in part by the interior surface of a chromatographic system. The flow path can be further defined at least in part by passageways through a frit of the chromatographic column. The flow path can be defined at least in part by interior surfaces of tubing. The flow path can be any flow path described herein, for example, the flow paths described with respect to the chromatographic device.
Methods of Improving Baseline Returns
Also provided herein is a method of improving baseline returns in a chromatographic system, the method comprising: introducing a sample including an analyte into a fluidic system including a flow path disposed in an interior of the fluidic system, the flow path having a length to diameter ratio of at least 20 and comprising a vapor deposited alkylsilyl coating having the Formula I, wherein the features for Formula I are as described above, a thickness of at least 100 angstroms and a contact angle of about 30 degrees to 110 degrees; and eluting the sample through the fluidic system, thereby isolating the biomolecule. In some embodiments, the method includes a second layer of Formula II or Formula III, wherein the features of Formula II and II are described above.
Kits
Also provided here are kits. The kits include a chromatographic components, for example, a chromatographic column, that has been coated with an alkylsilyl coating of Formulas I, II, and/or III, as described above. Other components can be provided in the kit that can also include the coatings described herein, for example, the tubing, frits, and/or connectors. The kit can also include instructions for separating analytes, for example, biomolecules, proteins, glycans, peptides, oligonucleotides, pesticides, bisphosphonic acids, anionic metabolites, and zwitterions like amino acids and neurotransmitters.
Exemplary Separations
Separation of Phosphoglygans
The disclosed coatings, which can be vapor deposited, have been found to dramatically improve separations of phosphoglycans by hydrophilic interaction chromatography (HILIC). To demonstrate the significance of this, the released N-glycans from a recombinant alpha-galactosidase which can be used as an enzyme replacement therapy for Fabry's disease were evaluated. This particular type of enzyme is taken up from circulation and delivered intercellularly to lysosomes through the mannose-6-phosphate pathway, making it important to identify and monitor the levels of phosphorylated glycans that are present on its surface. Vapor deposition coated stainless steel column tubes along with matching coated stainless steel frits were first tested against corresponding untreated stainless steel hardware. In this instance, two different types of coating chemistries were used. The coating chemistries used to coat the frits and tubing were VPD #2 and VPD #7.
The increased recovery of phosphorylated glycans using coated column hardware and fits shows that adsorption to metallic column hardware surfaces is detrimental to recovery. With this in mind, separations were also performed with vapor deposition coated stainless steel sample flow path components (
Separation of Other Phosphorylated Molecules
The principles learned from using vapor deposition coatings for phosphoglycan analysis were extended to facilitate the analysis of other types of phosphorylated biomolecules. In which case, the coatings have been found to be beneficial to improving the recovery of phosphorylated peptides under reversed phase chromatography conditions. To demonstrate these recovery advantages, we evaluated a mixture containing phosphopeptides. This particular sample contains three peptides that are singly phosphorylated and one that is doubly phosphorylated. Vapor deposition coated stainless steel column tubes along with matching coated stainless steel frits were first tested against corresponding untreated stainless steel hardware.
As such, in one aspect, the vapor deposition coated column hardware is used to improve the recovery of phosphorylated biomolecules during analyses by liquid chromatography. In yet another embodiment of this invention, vapor deposition coated flow path components are used in conjunction with vapor deposition coated column hardware to improve the recovery of phosphorylated biomolecules during analyses by liquid chromatography.
The effects of this finding have been demonstrated for two examples of phosphorylated biomolecules, phosphorylated glycans and phosphorylated peptides. Phosphorylated biomolecules refers to any molecule naturally produced by an organism that contains a phospho group, including but not limited to phosphorylated proteins and polynucleotides. Furthermore, it is reasonable to envision this disclosure being used to improve liquid chromatographic analyses of smaller biomolecules, including but not limited to phospholipids, nucleotides and sugar phosphates. Indeed, vapor deposition coated column hardware has been found to be useful in improving the recovery and peak shape of sugar phosphates and nucleotides. The effects of employing vapor deposition coated versus untreated column hardware for the reversed phase LC analyses of glucose-6-phosphate, fructose-6-phosphate, adenosine triphosphate, and adenosine monophosphate are captured in
Separation of Sialylated Glycans and Molecules Having Carboxylic Acid Moeities
It has additionally been discovered that vapor deposition coated hardware can be of benefit to mixed mode separations of sialylated glycans. In such a technique, sialylated glycans can be resolved using a stationary phase that exhibits anion exchange and reversed phase retention mechanisms. It was just recently discovered that a unique class of stationary phase, referred to as charged surface reversed phase chromatographic materials and described in International Application No. PCT/US2017/028856, entitled “CHARGED SURFACE REVERSED PHASE CHROMATOGRAPHIC MATERIALS METHOD FOR ANALYSIS OF GLYCANS MODIFIED WITH AMPHIPATHIC, STRONGLY BASED MOIETIES” and published as WO2017/189357 (and incorporated herein by reference in its entirety), is ideally suited to producing these types of separations. The use of a high purity chromatographic material (HPCM) with a chromatographic surface comprised of a diethylaminopropyl (DEAP) ionizable modifier, a C18 hydrophobic group and endcapping on a bridged ethylene hybrid particle has proven to be an exemplary embodiment for the separation of glycans labeled with amphipathic, strongly basic moieties, like that imparted by the novel labeling reagent described in International Application No. PCT/US2017/028856 (WO2017/189357). This so-called diethylaminopropyl high purity chromatographic material (DEAP HPCM) stationary phase is effective in separating acidic glycans as a result of it being modified with a relatively high pKa (˜10) ionizable modifier that yields uniquely pronounced anionic retention.
In an application to DEAP HPCM mixed mode separations of sialylated glycans, vapor deposition coated hardware has been shown to yield improved chromatographic recoveries and peak shapes of glycans containing greater than three sialic acid residues. A comparison of fluorescence chromatograms for fetuin N-glycans obtained with untreated stainless steel versus VPD #7 coated hardware is provided in
As with phosphorylated species, this effect on the chromatography of sialylated glycans is believed to result from masking the metallic surface of the hardware and minimizing adsorptive sample losses that can occur with analytes that exhibit a propensity for metal chelation. However, the origin of the metal chelation is different in that the effect is a consequence of a glycan carrying multiple carboxylate residues versus one or two phosphorylated residues. Carboxylate containing compounds generally have a weak affinity for metals. Yet, when there are multiple carboxylate moieties present in one molecule, an opportunity for polydentate chelation is created, as is the case with tetra- and penta-sialylated glycans.
Accordingly, in an embodiment of this invention, vapor deposition coated column hardware is used during liquid chromatography of biomolecules containing greater than three carboxylic acid residues as a means to improve their peak shape and recovery. In yet another embodiment of this invention, vapor deposition coated flow path components are used in conjunction with vapor deposition coated column hardware to improve the peak shape and recovery of biomolecules containing greater than three carboxylic acid residues.
Separation of Proteins
Certain vapor deposition coatings have also been found to beneficially impact protein reversed phase chromatography. To demonstrate such, we evaluated a paradigmatic protein separation that is very important to the analysis of biopharmaceuticals, a monoclonal (mAb) subunit separation with MS-friendly, formic acid modified mobile phase. Using such a test, numerous combinations of column hardware materials have been examined. Vapor deposition coated stainless steel column tubes along with matching coated stainless steel frits were first tested against corresponding untreated stainless steel hardware.
An effect such as this can be very significant to protein reversed phase separations, particularly those intended to facilitate detection by online electrospray ionization (ESI)-mass spectrometry (MS). Often, it is critical to have quick returns to baseline in ESI-MS data given that it will make the assignment of chromatographic peaks less ambiguous. Signal from previously eluted species will be less abundant and therefore less confounding in data accumulated for later eluting peaks. With this in mind, 11 additional combinations of column hardware materials were screened, using ESI-MS detection as the means to assessing the quality of the data.
As such, in an embodiment of this invention, vapor deposition coated column hardware is used to improve the chromatographic performance of protein reversed phase separations. In yet another embodiment of this invention, a vapor deposition coating with a contact angle of >90°, more preferably greater than 100 Å, is used to coat the tubing and frits of a column, or chromatographic device, as a means to improve the baseline and/or tailing factors of protein separations.
In a separate embodiment, this invention may utilize a frit material that is constructed of a specific polymer, such that an equivalently hydrophobic surface is achieved, specifically one with a contact angle greater than 90°, more preferably greater than 100 Å. Polytetrafluoroethylene (PTFE), polymethylpentene (PMP), high density polyethylene (HDPE), low density polyethylene (LDPE) and ultra high molecular weight polyethylene (UHMWPE) are examples of hydrophobic polymers that could be suitable for use as the frit or column material in other embodiments of this invention. In fact, an inlet frit constructed of porous PTFE (1.5 mm thick, Porex PM0515) was found to favorably affect protein reversed phase baselines, in a manner similar to that of the previously mentioned VPD #7 vapor deposition coated inlet frit (
Finally, vapor deposition coated hardware has been found to be of benefit to aqueous biomolecule separations, such as protein ion exchange chromatography. When looking to understand the charge heterogeneity of a sample, an analyst will often choose to resolve the components of a sample by ion exchange. In the case of protein therapeutics, this type of analysis is performed as a means to interrogate so-called charge variants, such as deamidiation variants, that can have a detrimental effect on the efficacy of the corresponding drug product. Charge variant separations by way of ion exchange can therefore be critical to the effectiveness of a characterization approach for a protein therapeutic, most particularly a monoclonal antibody. Being such an important analytical approach, protein ion exchange must be robust and able to quickly and reliably yield accurate information.
To this end, ion exchange separations of a monoclonal antibody were evaluated, and the effects of using uncoated versus vapor deposition coated column hardware were contrasted.
Here, it is clear that the noted vapor deposition coatings enhance the chromatographic properties of metallic hardware. Little can be seen in the way of distinguishing the chromatographic performance of the two tested vapor deposition coatings, namely the C2 and C2-GPTMS-OH chemistries. However, the C2-GPTMS-OH coating has an inordinately low contact angle (as does C2PEO). It is foreseeable that certain types and classes of biomolecules will require a highly hydrophilic flow path. One such example could indeed be aqueous protein separations in which hydrophobic interactions could lead to poor recovery or peak tailing. As a whole, it is believed that vapor deposition coated hardware will show advantages for numerous forms of aqueous separations, including but not limited to ion exchange, size exclusion and hydrophobic interaction chromatography, and that the most ideal vapor deposition coating would be one that is very hydrophilic. Accordingly, in an embodiment of this invention, a vapor deposition coated column is used to improve the recovery of samples from aqueous chromatographic separations. In a more specific embodiment, a vapor deposition coating with a contact angle less than 20° is used to improve the recovery of biomolecules in ion exchange, size exclusion or hydrophobic interaction chromatography.
C2 and C2C10 Vapor Deposition Coatings
Prior to coating, all metal components are passivated according to a nitric acid passivation. Passivated parts and a silicon wafer are then introduced to the vapor deposition chamber and vacuum is established. The first step is a 15 minute, 200 Watt, 200 cc/min oxygen plasma cleaning step. Next is the first vapor deposition cycle. Each vapor deposition cycle contains a silane vapor deposition, followed by the introduction of water vapor for silane hydrolysis. The silane vapor is delivered at a pressure of 2.0 Torr for 5 seconds, and then the water vapor is delivered at a pressure of 50 Torr for 5 seconds. Following delivery, the silane and water is left to react with the substrate for 15 minutes. This cycle is repeated to produce the desired number of layers and coating thickness. An additional processing cycle can be implemented to functionalize the coating with yet another silane. Moreover, a post coating annealing step can be used to further cross-link and increase the hydrophobicity of the coating. Typically, the annealing cycle involves subjecting the coating to 200° C. for 3 hours under vacuum.
A silicon wafer is used as a coupon to measure the thickness and contact angle of the coating. To measure the thickness, a Gaertner Scientific Corporation stokes ellipsometer model LSE is used. By analyzing the change in polarization of light, and comparing to a model, the film thickness can be established. To measure the contact angle, a Ramé-Hart goniometer model 190 is used. After dropping a controlled amount of water onto a perfectly level silicon wafer, optical techniques are used to measure the contact angle.
C2-GPTMS-OH Vapor Deposition Coatings
Prior to coating, all metal components are passivated according to a nitric acid passivation. Passivated parts and a silicon wafer are then introduced to the vapor deposition chamber and vacuum is established. The first step is a 15 minute, 200 Watt, 200 cc/min oxygen plasma cleaning step. Next is the first vapor deposition cycle. Each vapor deposition cycle contains a silane vapor deposition, followed by the introduction of water vapor for silane hydrolysis. The silane vapor is delivered at a pressure of 2.0 Torr for 5 seconds, and then the water vapor is delivered at a pressure of 50 Torr for 5 seconds. Following delivery, the silane and water is left to react with the substrate for 15 minutes. This cycle is repeated to produce the desired number of layers and coating thickness. In this example, the bis(trichlorosilyl)ethane silane is used to build up an adhesion or primer layer of approximately 800 Å. After C2 deposition, the 3-(glycidoxypropyl)trimethoxysilane is delivered anhydrously to a pressure of 0.4 Torr in the vapor deposition chamber. This silane vapor is left to react with the C2 coated substrate for one hour. This process results in an epoxide terminated coating, with a contact angle of 50°. After deposition, the next step is to hydrolyze the epoxide groups. This is performed either in the liquid phase or the vapor phase, with 0.1M acetic acid. After epoxide hydrolysis, the contact angle is <20°. Contact angle measurements are taken on a silicon wafer using a Ramé-Hart goniometer model 190.
Alternative Contact Angle Measurement
It is relatively easy to measure the contact angle on the flat silicon wafers using a goniometer. However, not all our substrates have such smooth and flat surfaces. Frits can be considered a chromatography column's most important substrate, since the fluidic surface area to mass ratio is higher in the frit than in any other column hardware component. In order to measure the solid-liquid wetting properties of frit porosity, and confirm the presence of a coating, we can use the bubble point test. The bubble point test is used to determine the largest pore diameter of a frit structure, and the bubble point pressure is related to this diameter with the following equation:
P=(2γ cos θ)/r
Where,
P=bubble point pressure, Pa (measured)
γ=surface tension of test liquid, N/m (known)
Θ=contact angle between test liquid and pore material (calculated)
r=largest pore radius, m (calculated)
This equation is from ASTM E128 and is derived from the equilibrium condition of capillary rise.
Using the bubble point test to calculate a contact angle requires two steps. This first is to test the frit in IPA, and assume a 0 contact angle, since IPA has excellent wetting characteristics. This will yield a maximum pore diameter. The next step is to repeat the experiment with water as the test liquid, and the known pore radius. This will yield the contact angle with water, relative to the assumed 0 degree contact angle of IPA.
Corrosion Performance of Silane Coatings
ASTM G48 Method A is used to rank the relative pitting corrosion performance of various grades of stainless steel. It consists of placing a part in ˜6% ferric chloride solution for 72 hours, and checking the mass loss of your component. The test can be run at room temperature, or at slightly elevated temperatures to increase the corrosion rate. The ferric chloride solution is similar to the environment inside a pit during “non-accelerated” pitting corrosion; an acidic, oxidizing, chloride containing environment. When an entire part of interest is submerged in the ferric chloride solution, pitting corrosion is greatly accelerated, with normal test times only being 72 hours.
HILIC-Fluorescence-MS of Phosphoglycans
A recombinant alpha-galactosidase was diluted to 2 mg/mL. A 7.5 uL aliquot of the protein solution was then added to a 1 mL reaction tube containing 15.3 μL of water and 6 μL of buffered 5% RapiGest SF solution-commercially available from Waters Corporation (Milford, Mass.) (50 mM HEPES-NaOH, pH 7.9). The mixture was placed in a heat block at 90° C. for 3 minutes. Thereafter, the reaction tube was allowed to cool at room temperature for 3 minutes. To the reaction tube, 1.2 μL of PNGase F was then added and incubated at 50° C. for 5 minutes. After incubation, the reaction was again allowed to cool at room temperature for 3 minutes. To a vial containing 9 mg of RapiFluor-MS reagent, 131 uL of anhydrous DMF was added and vortexed to create a labeling solution. A 12 uL volume of this labeling solution was next added to the reaction tube. This labeling reaction was allowed to proceed for 5 minutes to produce the final sample.
A fully porous amide HILIC stationary phase (1.7 um, 130 Å) was used in a 2.1×50 mm column dimension to chromatograph the samples at a flow rate of 0.4 mL/min and temperature of 60° C. The gradient flow conditions initiated with 75.0% organic solvent (Acetonitrile) and 25.0% aqueous eluent (50 mM ammonium formate, pH 4.4) followed by a 11.66 min linear gradient to 54.0% organic/46% aqueous eluent. The column was then cycled through an aqueous regeneration step at 100% aqueous mobile phase at a flow rate of 0.2 mL/min for one minute. After the aqueous regeneration, the column was equilibrated at initial conditions for 4 minutes. Species eluting during the above separations were detected serially via fluorescence (Ex 265/Em 425, 2 Hz) followed by online ESI-MS. Mass spectra were acquired with a Xevo G2-XS QToF mass spectrometer operating with a capillary voltage of 2.2 kV, source temperature of 120° C., desolvation temperature of 500° C., and sample cone voltage of 50 V. Mass spectra were acquired at a rate of 2 Hz with a resolution of approximately 40,000 over a range of 700-2000 m/z.
RPLC-UV-MS of Phosphopeptides
A vial of phosphopeptide test standard (Waters Corporation, Milford, Mass.) was reconstituted with 50 uL of 0.1% formic acid. A fully porous CSH C18 stationary phase material (1.7 um, 130 Å) was used in 2.1×50 mm column dimensions to chromatograph the samples at a flow rate of 0.2 mL/min at a temperature of 60° C. The gradient flow conditions initiated with 0.7% organic mobile phase (0.075% formic acid in acetonitrile) and 99.3% aqueous mobile phase (0.1% formic acid) followed by a 30 min linear gradient to 50% organic/50% aqueous. Species eluting during the above separations were detected serially via UV (220 nm) followed by online ESI-MS. Mass spectra were acquired with a Xevo G2-XS QToF mass spectrometer operating with a capillary voltage of 1.5 kV, source temperature of 100° C., desolvation temperature of 350° C., and sample cone voltage of 50 V. Mass spectra were acquired at a rate of 2 Hz with a resolution of approximately 40,000 over a range of 500-6500 m/z.
RPLC/MS of Small Biomolecules (Nucleotides and Sugar Phosphates)
RPLC/MS analyses of two nucleotides (adenosine monophosphate and adenosine triphosphate) and two sugar phosphates (glucose-6-phosphate and fructose-6-phosphate) were performed by reversed phase separations with an organosilica C18 stationary phase according to the methods parameters noted below.
LC Conditions
LC-Fluorescence-MS of Highly Sialylated Glycans Using Charge Surface Reversed Phase Chromatography
RapiFluor-MS labeled N-glycans were prepared from bovine fetuin (Sigma F3004) according to a previously published protocol (Lauber, M. A.; Yu, Y. Q.; Brousmiche, D. W.; Hua, Z.; Koza, S. M.; Magnelli, P.; Guthrie, E.; Taron, C. H.; Fountain, K. J., Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI-MS Detection. Anal Chem 2015, 87 (10), 5401-9). Analyses of these released glycans were performed using a Waters ACQUITY UPLC H-Class Bio LC system and a separation method based on a previously described charged surface reversed phase chromatographic material described in International Application No. PCT/US2017/028856, entitled “CHARGED SURFACE REVERSED PHASE CHROMATOGRAPHIC MATERIALS METHOD FOR ANALYSIS OF GLYCANS MODIFIED WITH AMPHIPATHIC, STRONGLY BASED MOIETIES” (and incorporated by reference). Specifically, RapiFluor-MS labeled glycans (e.g., glycans labeled with the labeling reagent discussed in PCT/US2017/028856 were separated according to a mixed mode separation using a fully porous (130 Å) 1.7 μm diethylaminopropyl high purity chromatographic material (DEAP HPCM) in a 2.1×100 mm column configuration. Details of the method are described below.
LC Conditions
LC/MS of a Reduced, IdeS Digested Monoclonal Antibody (mAb)
Formulated NIST mAb Reference Material 8671 (an IgG1κ) was added to 100 units of IdeS and incubated for 30 minutes at 37° C. The resulting IdeS-digested mAb was then denatured and reduced by the addition of 1M TCEP and solid GuHCl. The final buffer composition for the denaturation/reduction step was approximately 6 M GuHCl, 80 mM TCEP, and 10 mM phosphate (pH 7.1). IdeS-digested NIST RM 8671 (1.5 mg/mL) was incubated in this buffer at 37° C. for 1 hour, prior to being stored at 4° C. Reversed phase (RP) separations of the reduced, IdeS-fragmented mAb were performed to demonstrate the effects of employing different vapor deposition coated column hardware pieces, namely the column tube and the frits that enclose the stationary phase into its packing.
A C4 bonded superficially porous stationary phase (2 μm, Rho 0.63, 290 Å) was used in a 2.1×50 mm column dimension to chromatograph the samples at a flow rate of 0.2 mL/min and temperature of 80° C. across a linear gradient consisting of a 20 min linear gradient from 15 to 55% organic mobile phase (aqueous mobile phase: 0.1% (v/v) formic acid in water; organic mobile phase: 0.1% (v/v) formic acid in acetonitrile). Species eluting during the above separations were detected serially via fluorescence (Ex 280/Em 320, 10 Hz) followed by online ESI-MS. Mass spectra were acquired with a Synapt G2-S mass spectrometer operating with a capillary voltage of 3.0 kV, source temperature of 150° C., desolvation temperature of 350° C., and sample cone voltage of 45 V. Mass spectra were acquired at a rate of 2 Hz with a resolution of approximately 20,000 over a range of 500-4000 m/z.
Ion Exchange Chromatography
NIST mAb Reference Material 8671 (an IgG1κ) was separated using columns constructed from a 3 μm non-porous cation exchange stationary phase packed into either uncoated or vapor deposition coated hardware. Separations were performed with an ACQUITY UPLC H-Class Bio instrument according to the experimental conditions outlined below.
LC Conditions
Oligonucleotide Ion Pair RPLC
Testing has shown that flow paths modified with the vapor deposition coatings of this invention are also helpful in improving oligonucleotide separations. Example 11 provides evidence of such as observed in the form of improved recoveries and more accurate profiling of a sample's composition, particularly with respect to the first chromatograms obtained with a column.
In this work, a mixture of 15, 20, 25, 30, 35 and 40-mer deoxythymidine was separated using columns constructed from a 1.7 μm organosilica 130 Å C18 bonded stationary phase packed into either uncoated or vapor deposition coated hardware. Separations were performed with an ACQUITY UPLC H-Class Bio instrument according to the experimental conditions outlined below.
LC Conditions
RPLC of Citric and Malic Acid
It should also be pointed out that the benefits of this invention are not limited to only biomolecules or phosphorylated/phospho group containing analytes. In fact, numerous types of so-called “small molecules” can be seen to have their separations improved through the adoption of vapor deposition coated flow paths and column hardware. One notable class of small molecules corresponds to compounds having a carboxylic acid moiety. By their nature, these are ubiquitous compounds and some, like citric acid and malic acid, are important metabolites of living organisms, given that they are constituents of the Kreb's cycle.
Herein, we have investigated the effects of separating citric acid and malic acid with untreated versus vapor deposition coated columns. Citric acid and malic acid were analyzed by LC-MS with columns constructed from a 1.8 μm silica 100 Å C18 bonded stationary phase packed into either uncoated or C2C3 vapor deposition coated hardware. Separations were performed with an ACQUITY UPLC I-Class PLUS instrument, and eluting analytes were detected with a Xevo TQ-S triple quadrupole mass spectrometer according to the experimental conditions outlined below.
LC Conditions
MS Conditions
Mixed Mode Chromatography of Pesticides
Glyphosate is non-selective broad spectrum herbicide which is widely used across the globe as a crop desiccant. Maximum residue limits (MRLs) are enforced globally on various commodities of interest because of the potential health consequences posed to consumers. Glyphosate and its metabolite aminomethylphosphonic acid (AMPA) require unique approaches for sample preparation and chromatography separation. Various methods can be employed for quantitation, whether they are based on reversed phase, porous graphitizes carbon, ion chromatography, hydrophilic interaction chromatography (HILIC) or mixed mode retention mechanisms. No matter the separation mode, assays for glyphosate and other related herbicide compounds can prove to be problematic. First, polar pesticides are difficult to retain on reversed phase columns without derivatization. Second, glyphosate interacts with active metal surfaces. As a result, it is notoriously observed in the form of a broad peak or one with pronounced tailing.
Herein, we have investigated the separation of glyphosate with untreated versus vapor deposition coated mixed mode HILIC columns. Glyphosate was analyzed by LC-MS with 1.7 μm diethylamine bonded organosilica 130 Å columns constructed from either uncoated or C2C10 vapor deposition coated stainless steel hardware. Separations were performed with an ACQUITY UPLC H-Class Bio coupled with a Xevo TQ-XS triple quadrupole mass spectrometer according to the experimental conditions outlined below.
LC Conditions
MS Conditions
There are a number of alternative methods and uses for the present technology. While the above methods have generally been discussed with respect to chromatography or the use of a column. Other types of fluid components having an internal flow path may benefit from the present technology. For example, it is generally thought that capillary electrophoresis, such as capillary zone electrophoresis, exhibits relatively poor reproducibility. Much of the reproducibility issues can be reasoned to originate from irreproducible surface chemistry on the inner diameter of the tubular capillaries that are used to perform the separation. A vapor deposition coating on capillaries intended for a CE separation may therefore circumvent reproducibility issues as it can yield an inordinately thick, rugged coating. The inventions described herein may consequently be applicable to improving CE separations of both small and large biomolecules.
Moreover, while the examples of the described aspects employ comparatively hydrophobic coatings, with water contact angles ranging from 15° to 110°, it is reasonable to suggest that some separations could be enhanced through the application of hydrophilic coatings, including but not restricted to diol, amide/ureido type, and polyethylene oxide/glycol bondings.
Other analytes, not yet explicitly described, may also benefit from vapor deposition coated chromatographic flow paths, for instance phosphorothioated oligonucleotides. Nucleic acids inherently contain repeating phosphodiester bonds as part of their backbone. In some case, the phosphodiester backbone is replaced in part with a phosphorothioate backbone, which can impart in itself unique challenges for a separation. Similarly, intact and proteolytically digested antibody conjugates may benefit from methods entailing the use of vapor deposition chromatographic flow paths. Lastly, biomolecules containing histidine residues are likely to benefit from this invention as, like phosphorylated and carboxylate containing residues, they have a propensity for binding to metal.
This application claims priority to and benefit of U.S. provisional application No. 62/559,895 filed Sep. 18, 2017 entitled “Use of Vapor Deposition Coated Flow Paths for Improved Chromatography of Biomolecules,” the contents of which is incorporated herein by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2801186 | Alexander et al. | Jul 1957 | A |
| 4708782 | Andresen | Nov 1987 | A |
| 4711820 | Arkles et al. | Dec 1987 | A |
| 4833093 | Malmqvist et al. | May 1989 | A |
| 4945282 | Kawamura et al. | Jul 1990 | A |
| 4999162 | Wells et al. | Mar 1991 | A |
| 5002794 | Ratner et al. | Mar 1991 | A |
| 5153072 | Ratner et al. | Oct 1992 | A |
| 5470463 | Girot et al. | Nov 1995 | A |
| 5550184 | Halling | Aug 1996 | A |
| 5595813 | Ogawa et al. | Jan 1997 | A |
| 5643436 | Ogawa et al. | Jul 1997 | A |
| 5688855 | Stoy et al. | Nov 1997 | A |
| 5856192 | Bloch | Jan 1999 | A |
| 5876753 | Timmons et al. | Mar 1999 | A |
| 5909314 | Oka et al. | Jun 1999 | A |
| 6013372 | Hayakawa et al. | Jan 2000 | A |
| 6054227 | Greenberg et al. | Apr 2000 | A |
| 6074981 | Tada et al. | Jun 2000 | A |
| 6121608 | Takada | Sep 2000 | A |
| 6194346 | Tada et al. | Feb 2001 | B1 |
| 6207263 | Takematsu et al. | Mar 2001 | B1 |
| RE37183 | Kawamura et al. | May 2001 | E |
| 6265026 | Wang | Jul 2001 | B1 |
| 6306506 | Timmons et al. | Oct 2001 | B1 |
| 6329024 | Timmons et al. | Dec 2001 | B1 |
| 6329209 | Wagner et al. | Dec 2001 | B1 |
| 6337129 | Watanabe et al. | Jan 2002 | B1 |
| 6340404 | Oka et al. | Jan 2002 | B1 |
| 6383642 | Le Bellac et al. | May 2002 | B1 |
| 6440565 | Kim et al. | Aug 2002 | B1 |
| 6444326 | Smith | Sep 2002 | B1 |
| 6461334 | Buch-Rasmussen et al. | Oct 2002 | B1 |
| 6465056 | Chabrecek et al. | Oct 2002 | B1 |
| 6482531 | Timmons et al. | Nov 2002 | B1 |
| 6547868 | Belmares et al. | Apr 2003 | B1 |
| 6599594 | Walther et al. | Jul 2003 | B1 |
| 6660338 | Hargreaves | Dec 2003 | B1 |
| 6686035 | Jiang et al. | Feb 2004 | B2 |
| 6706408 | Jelle | Mar 2004 | B2 |
| 6743516 | Murphy et al. | Jun 2004 | B2 |
| 6763437 | Nguyen et al. | Jul 2004 | B1 |
| 6783800 | Saito et al. | Aug 2004 | B2 |
| 6844028 | Mao et al. | Jan 2005 | B2 |
| 6873387 | Hokazono et al. | Mar 2005 | B2 |
| 6905772 | Shoup et al. | Jun 2005 | B2 |
| 6916541 | Pantano et al. | Jul 2005 | B2 |
| 6991826 | Pellerite et al. | Jan 2006 | B2 |
| 7067194 | Mao et al. | Jun 2006 | B2 |
| 7138186 | Luten, III | Nov 2006 | B2 |
| 7250214 | Walter et al. | Jul 2007 | B2 |
| 7285674 | Palma et al. | Oct 2007 | B2 |
| 7294365 | Hayakawa et al. | Nov 2007 | B2 |
| 7351477 | Yamaya et al. | Apr 2008 | B2 |
| 7387836 | Gianolio et al. | Jun 2008 | B2 |
| 7413774 | Kobrin et al. | Aug 2008 | B2 |
| 7419636 | Aker et al. | Sep 2008 | B2 |
| 7419699 | Kitada et al. | Sep 2008 | B2 |
| 7431969 | Gleason et al. | Oct 2008 | B2 |
| 7553514 | Fan et al. | Jun 2009 | B2 |
| 7629029 | Mao et al. | Dec 2009 | B2 |
| 7638167 | Kobrin et al. | Dec 2009 | B2 |
| 7687239 | Goldberg et al. | Mar 2010 | B2 |
| 7695775 | Kobrin et al. | Apr 2010 | B2 |
| 7776396 | Kobrin et al. | Aug 2010 | B2 |
| 7785649 | Jung et al. | Aug 2010 | B2 |
| 7815922 | Chaney et al. | Oct 2010 | B2 |
| 7842393 | Kuzuya et al. | Nov 2010 | B2 |
| 7879396 | Kobrin et al. | Feb 2011 | B2 |
| 7901744 | Denes et al. | Mar 2011 | B2 |
| 7955656 | Murayama et al. | Jun 2011 | B2 |
| 7955704 | Lowery et al. | Jun 2011 | B2 |
| 8008225 | Henze et al. | Aug 2011 | B2 |
| 8025915 | Haines et al. | Sep 2011 | B2 |
| 8062881 | Bookbinder et al. | Nov 2011 | B2 |
| 8105821 | McGall et al. | Jan 2012 | B2 |
| 8147954 | Lee et al. | Apr 2012 | B2 |
| 8163354 | Dang et al. | Apr 2012 | B2 |
| 8178168 | O'Neill et al. | May 2012 | B2 |
| 8178602 | Mao et al. | May 2012 | B2 |
| 8323166 | Haines et al. | Dec 2012 | B2 |
| 8349408 | Dulka et al. | Jan 2013 | B2 |
| 8366814 | Jones et al. | Feb 2013 | B2 |
| 8404621 | Ikeda et al. | Mar 2013 | B2 |
| 8512864 | Konno et al. | Aug 2013 | B2 |
| 8557748 | Ikeda et al. | Oct 2013 | B2 |
| 8580355 | Durandeau et al. | Nov 2013 | B2 |
| 8652588 | Teer et al. | Feb 2014 | B2 |
| 8668972 | Lewis et al. | Mar 2014 | B2 |
| 8691104 | Greer et al. | Apr 2014 | B2 |
| 8709588 | Cadet et al. | Apr 2014 | B2 |
| 8741158 | Aytug et al. | Jun 2014 | B2 |
| 8778278 | Xiong et al. | Jul 2014 | B2 |
| 8784565 | Hillabrand et al. | Jul 2014 | B2 |
| 8795787 | Jehle | Aug 2014 | B2 |
| 8841070 | Harnack et al. | Sep 2014 | B2 |
| 8992590 | Ott et al. | Mar 2015 | B2 |
| 8993479 | Zuilhof et al. | Mar 2015 | B2 |
| 9034660 | Boday et al. | May 2015 | B2 |
| 9075189 | West | Jul 2015 | B2 |
| 9108012 | Pryce Lewis et al. | Aug 2015 | B2 |
| 9175026 | Garrell et al. | Nov 2015 | B2 |
| 9255929 | Jiang et al. | Feb 2016 | B2 |
| 9272095 | Felts et al. | Mar 2016 | B2 |
| 9308520 | Ekeroth | Apr 2016 | B2 |
| 9340880 | Mattzela | May 2016 | B2 |
| 9364853 | Chen | Jun 2016 | B2 |
| 9388315 | Hoshino | Jul 2016 | B2 |
| 9445504 | Kang et al. | Sep 2016 | B2 |
| 9475225 | Giraud et al. | Oct 2016 | B2 |
| 9523004 | Hervieu et al. | Dec 2016 | B2 |
| 9533006 | Jiang et al. | Jan 2017 | B2 |
| 9541480 | Chang et al. | Jan 2017 | B2 |
| 9556360 | McGall et al. | Jan 2017 | B2 |
| 9777368 | Smith et al. | Oct 2017 | B2 |
| 9915001 | Yuan et al. | Mar 2018 | B2 |
| 9925521 | Wyndham et al. | Mar 2018 | B2 |
| 9926203 | Zhou | Mar 2018 | B2 |
| 9975143 | Smith et al. | May 2018 | B2 |
| 9999901 | Boscher et al. | Jun 2018 | B2 |
| 10472769 | Tuteja et al. | Nov 2019 | B2 |
| 10813609 | Goto et al. | Oct 2020 | B2 |
| 10813610 | Yoshida et al. | Oct 2020 | B2 |
| 10814253 | Lipkens et al. | Oct 2020 | B2 |
| 10814305 | Liao et al. | Oct 2020 | B2 |
| 10814319 | Dasgupta et al. | Oct 2020 | B2 |
| 10814320 | Le et al. | Oct 2020 | B2 |
| 10814740 | Wilhide | Oct 2020 | B2 |
| 10815247 | Flemming et al. | Oct 2020 | B2 |
| 10815269 | Maloisel et al. | Oct 2020 | B2 |
| 10816115 | Buerger et al. | Oct 2020 | B2 |
| 10816476 | Nunney et al. | Oct 2020 | B2 |
| 10816487 | Matney et al. | Oct 2020 | B2 |
| 10816515 | Hollnagel et al. | Oct 2020 | B2 |
| 10816518 | Jarrold et al. | Oct 2020 | B2 |
| 10816786 | Douglas-Hamilton et al. | Oct 2020 | B2 |
| 10818485 | Yamaguchi | Oct 2020 | B2 |
| 10818486 | Corr et al. | Oct 2020 | B2 |
| 10828665 | Stiff-Roberts et al. | Nov 2020 | B2 |
| 10876202 | Verbeck, IV et al. | Dec 2020 | B2 |
| 10876210 | Claussen et al. | Dec 2020 | B1 |
| 10895009 | Carr et al. | Jan 2021 | B2 |
| 10912714 | Weikart et al. | Feb 2021 | B2 |
| 20010021446 | Takematsu et al. | Sep 2001 | A1 |
| 20020016250 | Hayakawa et al. | Feb 2002 | A1 |
| 20020020053 | Fonash et al. | Feb 2002 | A1 |
| 20020026899 | McLaughlin et al. | Mar 2002 | A1 |
| 20020142621 | Wang | Oct 2002 | A1 |
| 20020172938 | Cuomo et al. | Nov 2002 | A1 |
| 20020195950 | Mikhael et al. | Dec 2002 | A1 |
| 20030059573 | Timmons et al. | Mar 2003 | A1 |
| 20030109062 | Inomata et al. | Jun 2003 | A1 |
| 20030113477 | Timmons et al. | Jun 2003 | A1 |
| 20030138645 | Gleason et al. | Jul 2003 | A1 |
| 20040261703 | Kobrin et al. | Dec 2004 | A1 |
| 20050118595 | Lahann | Jun 2005 | A1 |
| 20050164402 | Belisle et al. | Jul 2005 | A1 |
| 20050214803 | Wang | Sep 2005 | A1 |
| 20060073521 | Saito et al. | Apr 2006 | A1 |
| 20060110594 | Frutos et al. | May 2006 | A1 |
| 20060213441 | Kobrin et al. | Sep 2006 | A1 |
| 20060219598 | Cody et al. | Oct 2006 | A1 |
| 20060251795 | Kobrin et al. | Nov 2006 | A1 |
| 20070048747 | Leslie et al. | Mar 2007 | A1 |
| 20070065591 | Parbhu | Mar 2007 | A1 |
| 20070122308 | Ikeda et al. | May 2007 | A1 |
| 20070172666 | Denes et al. | Jul 2007 | A1 |
| 20080041105 | Hahn et al. | Feb 2008 | A1 |
| 20080170230 | Gerion | Jul 2008 | A1 |
| 20080188010 | Saitoh et al. | Aug 2008 | A1 |
| 20080248589 | Belisle et al. | Oct 2008 | A1 |
| 20080312356 | Kobrin et al. | Dec 2008 | A1 |
| 20090020712 | Matsumoto | Jan 2009 | A1 |
| 20090081371 | Minami et al. | Mar 2009 | A1 |
| 20090162571 | Haines et al. | Jun 2009 | A1 |
| 20090176084 | Yoshihara et al. | Jul 2009 | A1 |
| 20090206034 | Nakajima | Aug 2009 | A1 |
| 20090286435 | Badyal et al. | Nov 2009 | A1 |
| 20090318609 | Badyal et al. | Dec 2009 | A1 |
| 20100080903 | Tamitsuji et al. | Apr 2010 | A1 |
| 20100178512 | Giesenberg et al. | Jul 2010 | A1 |
| 20100196724 | Yamasaki et al. | Aug 2010 | A1 |
| 20100200207 | Fukuda et al. | Aug 2010 | A1 |
| 20100203646 | Larsen et al. | Aug 2010 | A1 |
| 20100330278 | Choi et al. | Dec 2010 | A1 |
| 20110000658 | Tanaka et al. | Jan 2011 | A1 |
| 20110062047 | Haines et al. | Mar 2011 | A1 |
| 20110120213 | Hirayama | May 2011 | A1 |
| 20110120940 | Allen et al. | May 2011 | A1 |
| 20110189493 | Ott et al. | Aug 2011 | A1 |
| 20120069295 | Fukagawa et al. | Mar 2012 | A1 |
| 20120123345 | Felts et al. | May 2012 | A1 |
| 20120178848 | Adkinson et al. | Jul 2012 | A1 |
| 20120219697 | Chen | Aug 2012 | A1 |
| 20120219727 | Gandhiraman et al. | Aug 2012 | A1 |
| 20120251797 | Smith et al. | Oct 2012 | A1 |
| 20120252709 | Felts et al. | Oct 2012 | A1 |
| 20120288717 | Mao et al. | Nov 2012 | A1 |
| 20130004780 | Hervieu et al. | Jan 2013 | A1 |
| 20130025503 | Park et al. | Jan 2013 | A1 |
| 20130029138 | Benard et al. | Jan 2013 | A1 |
| 20130136937 | Fujii et al. | May 2013 | A1 |
| 20130157062 | Kihara et al. | Jun 2013 | A1 |
| 20130244025 | Smith et al. | Sep 2013 | A1 |
| 20130266762 | Mayers et al. | Oct 2013 | A1 |
| 20130337226 | Curran et al. | Dec 2013 | A1 |
| 20140004022 | Sagona et al. | Jan 2014 | A1 |
| 20140065368 | Aytug et al. | Mar 2014 | A1 |
| 20140147631 | Yang et al. | May 2014 | A1 |
| 20140154399 | Weikart et al. | Jun 2014 | A1 |
| 20140187666 | Aizenberg et al. | Jul 2014 | A1 |
| 20140202355 | Hoshino | Jul 2014 | A1 |
| 20140287240 | Murotani et al. | Sep 2014 | A1 |
| 20140299538 | Gleason et al. | Oct 2014 | A1 |
| 20140318748 | Svensson et al. | Oct 2014 | A1 |
| 20140323981 | Giraud et al. | Oct 2014 | A1 |
| 20140342954 | Ingber et al. | Nov 2014 | A1 |
| 20140357091 | Mattzela | Dec 2014 | A1 |
| 20140370300 | Smith | Dec 2014 | A1 |
| 20150021339 | Felts et al. | Jan 2015 | A1 |
| 20150024152 | Carr et al. | Jan 2015 | A1 |
| 20150030885 | Smith | Jan 2015 | A1 |
| 20150064376 | Smith et al. | Mar 2015 | A1 |
| 20150064451 | Kalaga et al. | Mar 2015 | A1 |
| 20150098084 | Felts et al. | Apr 2015 | A1 |
| 20150118502 | Mitsuhashi et al. | Apr 2015 | A1 |
| 20150118504 | Ohshita et al. | Apr 2015 | A1 |
| 20150122365 | Carr et al. | May 2015 | A1 |
| 20150152124 | Mori et al. | Jun 2015 | A1 |
| 20150175814 | Aizenberg et al. | Jun 2015 | A1 |
| 20150209846 | Aizanberg et al. | Jul 2015 | A1 |
| 20150210951 | Aizenberg et al. | Jul 2015 | A1 |
| 20150232806 | Jung et al. | Aug 2015 | A1 |
| 20150239773 | Aytug | Aug 2015 | A1 |
| 20150247051 | Ha et al. | Sep 2015 | A1 |
| 20150273522 | Boscher et al. | Oct 2015 | A1 |
| 20150283307 | Smith | Oct 2015 | A1 |
| 20150298165 | Smith | Oct 2015 | A1 |
| 20150307525 | Higano et al. | Oct 2015 | A1 |
| 20150307719 | Mitsuhashi et al. | Oct 2015 | A1 |
| 20150309216 | Fournand | Oct 2015 | A1 |
| 20150322272 | Pokroy et al. | Nov 2015 | A1 |
| 20150329725 | Liu | Nov 2015 | A1 |
| 20160002488 | Takao et al. | Jan 2016 | A1 |
| 20160002489 | Gleason et al. | Jan 2016 | A1 |
| 20160038972 | Lu | Feb 2016 | A1 |
| 20160040039 | Yamane et al. | Feb 2016 | A1 |
| 20160059260 | Smith et al. | Mar 2016 | A1 |
| 20160074862 | Breaux et al. | Mar 2016 | A1 |
| 20160168021 | Goh et al. | Jun 2016 | A1 |
| 20160200941 | Liu et al. | Jul 2016 | A1 |
| 20160231594 | Ang et al. | Aug 2016 | A1 |
| 20160243308 | Giraud et al. | Aug 2016 | A1 |
| 20160251261 | Bureau | Sep 2016 | A1 |
| 20160289824 | Mattzela | Oct 2016 | A1 |
| 20160302723 | Chen | Oct 2016 | A1 |
| 20160340544 | Katsukawa et al. | Nov 2016 | A1 |
| 20170001956 | Chau et al. | Jan 2017 | A1 |
| 20170044315 | Mitsuhashi et al. | Feb 2017 | A1 |
| 20170173223 | Delaney, Jr. et al. | Jun 2017 | A1 |
| 20180049644 | Themelis | Feb 2018 | A1 |
| 20180357402 | Omata et al. | Dec 2018 | A1 |
| 20190032201 | Smith et al. | Jan 2019 | A1 |
| 20190077966 | Koguchi et al. | Mar 2019 | A1 |
| 20190390329 | Carr et al. | Dec 2019 | A1 |
| 20200024155 | Kano et al. | Jan 2020 | A1 |
| 20200024156 | Kano et al. | Jan 2020 | A1 |
| 20200024157 | Kano et al. | Jan 2020 | A1 |
| 20200062615 | Rajagopalan et al. | Feb 2020 | A1 |
| 20200189938 | Kano et al. | Jun 2020 | A1 |
| 20200215457 | DeLano et al. | Jul 2020 | A1 |
| 20200239641 | Kawakami et al. | Jul 2020 | A1 |
| 20200328073 | Peterson et al. | Oct 2020 | A1 |
| 20200332801 | Kimura | Oct 2020 | A1 |
| 20200333265 | Doki et al. | Oct 2020 | A1 |
| 20200333369 | Toyoda et al. | Oct 2020 | A1 |
| 20200334792 | Themelis | Oct 2020 | A1 |
| 20200335902 | Tanaka | Oct 2020 | A1 |
| 20200337659 | Sano et al. | Oct 2020 | A1 |
| 20200338528 | Dong et al. | Oct 2020 | A1 |
| 20200339322 | Christensen et al. | Oct 2020 | A1 |
| 20200339665 | Bruhlmann et al. | Oct 2020 | A1 |
| 20200339931 | Bremer et al. | Oct 2020 | A1 |
| 20200339977 | Lebofsky et al. | Oct 2020 | A1 |
| 20200339980 | Dellinger et al. | Oct 2020 | A1 |
| 20200340047 | Mollerup | Oct 2020 | A1 |
| 20200340468 | Kuntz et al. | Oct 2020 | A1 |
| 20200340889 | Mlcak et al. | Oct 2020 | A1 |
| 20200340890 | Mlcak | Oct 2020 | A1 |
| 20200340910 | Handique | Oct 2020 | A1 |
| 20200340946 | Bateman et al. | Oct 2020 | A1 |
| 20200340949 | Mlcak et al. | Oct 2020 | A1 |
| 20200340950 | Mlcak et al. | Oct 2020 | A1 |
| 20200340956 | Ortmann et al. | Oct 2020 | A1 |
| 20200340959 | Schultz et al. | Oct 2020 | A1 |
| 20200340961 | Kunimura | Oct 2020 | A1 |
| 20200340982 | Levin et al. | Oct 2020 | A1 |
| 20200341253 | Foelling | Oct 2020 | A1 |
| 20200341255 | Chan | Oct 2020 | A1 |
| 20200341259 | Chan et al. | Oct 2020 | A1 |
| 20200341278 | Tanaka | Oct 2020 | A1 |
| 20200341378 | Wolterink et al. | Oct 2020 | A1 |
| 20200342326 | Rahnama Moghaddam | Oct 2020 | A1 |
| 20200342672 | Schmelig et al. | Oct 2020 | A1 |
| 20200343082 | Richardson et al. | Oct 2020 | A1 |
| 20200365237 | Madden et al. | Nov 2020 | A1 |
| 20200375846 | Chang et al. | Dec 2020 | A1 |
| 20210009883 | Tuteja et al. | Jan 2021 | A1 |
| 20210032157 | Czihal et al. | Feb 2021 | A1 |
| 20210061049 | Lekon et al. | Mar 2021 | A1 |
| 20210098233 | Kapoor et al. | Apr 2021 | A1 |
| 20210101176 | Baltazar et al. | Apr 2021 | A1 |
| Number | Date | Country |
|---|---|---|
| 2020244497 | Oct 2020 | AU |
| 2538124 | Jul 2010 | CA |
| 2881275 | Oct 2020 | CA |
| 2855353 | Jan 2021 | CA |
| 104327663 | Feb 2015 | CN |
| 109225113 | Jan 2019 | CN |
| 109608680 | Apr 2019 | CN |
| 111471977 | Jul 2020 | CN |
| 111560172 | Aug 2020 | CN |
| 111848755 | Oct 2020 | CN |
| 111855826 | Oct 2020 | CN |
| 111855827 | Oct 2020 | CN |
| 111863585 | Oct 2020 | CN |
| 111944153 | Nov 2020 | CN |
| 112011055 | Dec 2020 | CN |
| 112264272 | Jan 2021 | CN |
| 1816155 | Jun 2011 | EP |
| 2608219 | Mar 2015 | EP |
| 2915833 | Sep 2015 | EP |
| 3573646 | Dec 2019 | EP |
| 3633366 | Apr 2020 | EP |
| 2403621 | Oct 2020 | EP |
| 2798664 | Oct 2020 | EP |
| 2834837 | Oct 2020 | EP |
| 2900819 | Oct 2020 | EP |
| 3006980 | Oct 2020 | EP |
| 3060325 | Oct 2020 | EP |
| 3131657 | Oct 2020 | EP |
| 3139150 | Oct 2020 | EP |
| 3169232 | Oct 2020 | EP |
| 3169424 | Oct 2020 | EP |
| 3273674 | Oct 2020 | EP |
| 3344317 | Oct 2020 | EP |
| 3399074 | Oct 2020 | EP |
| 3545085 | Oct 2020 | EP |
| 3727152 | Oct 2020 | EP |
| 3727637 | Oct 2020 | EP |
| 3727679 | Oct 2020 | EP |
| 3727690 | Oct 2020 | EP |
| 3728046 | Oct 2020 | EP |
| 3728581 | Oct 2020 | EP |
| 3728621 | Oct 2020 | EP |
| 3728633 | Oct 2020 | EP |
| 3729055 | Oct 2020 | EP |
| 3729071 | Oct 2020 | EP |
| 3729077 | Oct 2020 | EP |
| 3729083 | Oct 2020 | EP |
| 3729162 | Oct 2020 | EP |
| 3729487 | Oct 2020 | EP |
| 3729488 | Oct 2020 | EP |
| 3730119 | Oct 2020 | EP |
| 3730324 | Oct 2020 | EP |
| 3730406 | Oct 2020 | EP |
| 3730538 | Oct 2020 | EP |
| 3730599 | Oct 2020 | EP |
| 3730922 | Oct 2020 | EP |
| 3730923 | Oct 2020 | EP |
| 3730927 | Oct 2020 | EP |
| 3731393 | Oct 2020 | EP |
| 3749719 | Dec 2020 | EP |
| 3788181 | Mar 2021 | EP |
| 3095337 | Oct 2020 | FR |
| 2108403 | May 1983 | GB |
| 2429428 | Feb 2007 | GB |
| 2481687 | Jan 2012 | GB |
| 2490243 | Oct 2012 | GB |
| 2501803 | Nov 2013 | GB |
| 2531126 | Apr 2016 | GB |
| 2549248 | Oct 2017 | GB |
| 2534477 | Oct 2020 | GB |
| 2574723 | Oct 2020 | GB |
| 174122 | Sep 2011 | IL |
| 239213 | Mar 2020 | IL |
| 253518 | Jun 2020 | IL |
| 262854 | Jun 2020 | IL |
| 2012232870 | Nov 2012 | JP |
| 2020507460 | Mar 2020 | JP |
| 2020507462 | Mar 2020 | JP |
| 2020507466 | Mar 2020 | JP |
| 2020510522 | Apr 2020 | JP |
| 6770727 | Oct 2020 | JP |
| 6771390 | Oct 2020 | JP |
| 6771801 | Oct 2020 | JP |
| 6772721 | Oct 2020 | JP |
| 6772764 | Oct 2020 | JP |
| 6772953 | Oct 2020 | JP |
| 6773138 | Oct 2020 | JP |
| 6773236 | Oct 2020 | JP |
| 2020169857 | Oct 2020 | JP |
| 2020171429 | Oct 2020 | JP |
| 2020171482 | Oct 2020 | JP |
| 2020171483 | Oct 2020 | JP |
| 2020171484 | Oct 2020 | JP |
| 2020171882 | Oct 2020 | JP |
| 2020172518 | Oct 2020 | JP |
| 2020172703 | Oct 2020 | JP |
| 2020173192 | Oct 2020 | JP |
| 2020173427 | Oct 2020 | JP |
| 2020176195 | Oct 2020 | JP |
| 2020177669 | Oct 2020 | JP |
| 2020530329 | Oct 2020 | JP |
| 2020530909 | Oct 2020 | JP |
| 2020536764 | Dec 2020 | JP |
| 960007179 | May 1996 | KR |
| 20000019936 | Apr 2000 | KR |
| 20060130959 | Dec 2006 | KR |
| 20080071942 | Aug 2008 | KR |
| 20120007817 | Jan 2012 | KR |
| 20130020869 | Mar 2013 | KR |
| 20140082838 | Jul 2014 | KR |
| 101711786 | Mar 2017 | KR |
| 20170021957 | Mar 2017 | KR |
| 101742683 | Jun 2017 | KR |
| 20180008427 | Jan 2018 | KR |
| 20200139842 | Dec 2020 | KR |
| 20210008523 | Jan 2021 | KR |
| 102218186 | Feb 2021 | KR |
| 20210013582 | Feb 2021 | KR |
| 202031738 | Sep 2020 | TW |
| 202039644 | Nov 2020 | TW |
| 1998017407 | Apr 1998 | WO |
| 1999040038 | Aug 1999 | WO |
| 199951773 | Oct 1999 | WO |
| 200032044 | Jun 2000 | WO |
| 200168240 | Sep 2001 | WO |
| 2002085250 | Oct 2002 | WO |
| 2002085330 | Oct 2002 | WO |
| 2006015982 | Feb 2006 | WO |
| 2007081387 | Jul 2007 | WO |
| 2007117191 | Oct 2007 | WO |
| 2007117213 | Oct 2007 | WO |
| 2007117214 | Oct 2007 | WO |
| 2009007150 | Jan 2009 | WO |
| 2010009311 | Jan 2010 | WO |
| 2010135660 | Nov 2010 | WO |
| 2012170549 | Dec 2012 | WO |
| 2014104495 | Jul 2014 | WO |
| 2014104573 | Jul 2014 | WO |
| 2014164928 | Oct 2014 | WO |
| 2015050449 | Apr 2015 | WO |
| 2015054652 | Apr 2015 | WO |
| 2015134488 | Sep 2015 | WO |
| 2016100923 | Jun 2016 | WO |
| 2016114850 | Jul 2016 | WO |
| 2016125272 | Aug 2016 | WO |
| 2016160702 | Oct 2016 | WO |
| 2016166816 | Oct 2016 | WO |
| 2017040623 | Mar 2017 | WO |
| 2017053891 | Mar 2017 | WO |
| 2017060991 | Apr 2017 | WO |
| 2017072893 | May 2017 | WO |
| 2017087032 | May 2017 | WO |
| 2017098758 | Jun 2017 | WO |
| 2017143246 | Aug 2017 | WO |
| 2017171546 | Oct 2017 | WO |
| 2017210223 | Dec 2017 | WO |
| 2018072862 | Apr 2018 | WO |
| 2018146318 | Aug 2018 | WO |
| 2018202935 | Nov 2018 | WO |
| 2019053693 | Mar 2019 | WO |
| 2019063482 | Apr 2019 | WO |
| 2019101980 | May 2019 | WO |
| 2019116619 | Jun 2019 | WO |
| 2019122100 | Jun 2019 | WO |
| 2019126130 | Jun 2019 | WO |
| 2019130536 | Jul 2019 | WO |
| 2019138705 | Jul 2019 | WO |
| 2019150573 | Aug 2019 | WO |
| 2019152724 | Aug 2019 | WO |
| 2019154758 | Aug 2019 | WO |
| 2019155543 | Aug 2019 | WO |
| 2019155545 | Aug 2019 | WO |
| 2019165297 | Aug 2019 | WO |
| 2019168989 | Sep 2019 | WO |
| 2019171085 | Sep 2019 | WO |
| 2019175441 | Sep 2019 | WO |
| 2019176081 | Sep 2019 | WO |
| 2019180045 | Sep 2019 | WO |
| 2019185607 | Oct 2019 | WO |
| 2019186999 | Oct 2019 | WO |
| 2019191587 | Oct 2019 | WO |
| 2019193558 | Oct 2019 | WO |
| 2019198280 | Oct 2019 | WO |
| 2019200306 | Oct 2019 | WO |
| 2019212799 | Nov 2019 | WO |
| 2019218088 | Nov 2019 | WO |
| 2019224201 | Nov 2019 | WO |
| 2019224540 | Nov 2019 | WO |
| 2019229171 | Dec 2019 | WO |
| 2019238469 | Dec 2019 | WO |
| 2019241394 | Dec 2019 | WO |
| 2020068174 | Apr 2020 | WO |
| 2020095566 | May 2020 | WO |
| 2020104521 | May 2020 | WO |
| 2020213061 | Oct 2020 | WO |
| 2020213101 | Oct 2020 | WO |
| 2020213209 | Oct 2020 | WO |
| 2020216966 | Oct 2020 | WO |
| 2020219451 | Oct 2020 | WO |
| 2020219605 | Oct 2020 | WO |
| 2020219659 | Oct 2020 | WO |
| 2020219667 | Oct 2020 | WO |
| 2020219671 | Oct 2020 | WO |
| 2020219784 | Oct 2020 | WO |
| 2020219869 | Oct 2020 | WO |
| 2021019220 | Feb 2021 | WO |
| 2021061049 | Apr 2021 | WO |
| 2021072245 | Apr 2021 | WO |
| Entry |
|---|
| HPLC Hardware. Möller Medical. (2007). |
| NanoCoatings Product Information. Möller Medical. (2010). |
| Al-Hamameh et al. “Synthesis and characterization of di(ethylene glycol) vinyl ether films deposited by atmospheric pressure corona discharge plasma.” Surface Coatings Technol. 234(2013):33-41. |
| Beigbeder et al. “Marine Fouling Release Silicone/Carbon Nanotube Nanocomposite Coatings: On the Importance of the Nanotube Dispersion State.” J. Nanosci. Nanotech, 10(2010): 2972-2978. |
| Biocyl™ X1, Dec. 20, 2018. |
| Carretier et al. “Design of PVDF/PEGMA-b-PS-b-PEGMA membranes by VIPS for improved biofouling mitigation.” J. Membrane Sci. 510(2016):355-369. |
| Dursan® Coating for Improved, Metal-Free Liquid Chromatography. Dec. 20, 2018. |
| Dursan® Data Sheet 2018. |
| Hsieh et al. “Effective Enhancement of Fluorescence Detection Efficiency in Protein Microarray assays: Application of a Highly Fluorinated Organosilane as the Blocking Agent on the Background Surface by a Facile Vapor-Phase Deposition Process.” Anal. Chem. 81(2009): 7908-7916. |
| Kaliaraj et al. “Bio-inspired YSZ coated titanium by EB-PVD for biomedical applications.” Surface and Coatings Technol. 307(2016): 227-235. |
| Lauber et al. “Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI-MS Detection.” Anal Chem. 87.10(2015): 5401-9. |
| Lecloux et al. “The safe use of carbon nanotubes in coating applications.” OECD Conference on Benefits of nanomaterials. Paris, Jul. 15-17, 2009. |
| Rosmaninho et al. “Modified stainless steel surfaces targeted to reduce fouling—Evaluation of fouling by milk components.” J. Food Engineering. 80(2007): 1176-1187. |
| Sun et al. “Vapor-based Grafting of Crosslinked Poly(N-vinyl pyrrolidone) Coatings with Tuned Hydrophilicity and Anti-Biofouling Properties.” J. Mater. Chem. B. 4(2016): 2669-2678. |
| Vaidya et al. “Protein-resistant properties of a chemical vapor deposited alkyl-functional carboxysilane coating characterized using quartz crystal microbalance.” Appl. Surface Sci. 364(2016): 896-908. |
| Velox Plus, Dec. 20, 2018. |
| Xue et al. “Surface-modified anodic aluminum oxide membrane with hydroxyethyl celluloses as a matrix for bilirubin removal.” J. Chromatog. B. 912(2013):1-7. |
| Yang et al. “Synergistic Prevention of Biofouling in Seawater Desalination by Zwitterionic Surfaces and Low-Level Chloronation.” Adv. Mater. 26(2014): 1711-1718. |
| Shih et al. “Silanization of Stainless-Steel Frits for Use in Trace Metal Analysis by High Performance Liquid Chromatography.” Talanta. 28(1981): 411-414. |
| Cheong. “Fritting techniques in chromatography.” J. Sep. Sci. 37(2014): 603-617. |
| Rahimi et al. “Application of copolymer coated frits for solid-phase extraction of poly cyclic aromatic hydrocarbons in water samples.” Anal. Chim. Acta. 836(2014): 45-52. |
| International Search Report and Written Opinion issued in International Application No. PCT/IB2021/059534 dated Mar. 10, 2022. |
| Kanavarioti et al. “HPLC methods for purity evaluation of man-made single-stranded RNAs.” Nature. 9(2019): 1019. |
| Wyndham et al. “Characterization and Evaluation of C18 HPLC Stationary Phases Based on Ethyl-Bridged Hybrid Organic/Inorganic Particles.” Anal. Chem. 75.24(2003): 6781-6788. |
| Number | Date | Country | |
|---|---|---|---|
| 20190086371 A1 | Mar 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62559895 | Sep 2017 | US |
